methotrexate has been researched along with Graft-Versus-Host Disease in 711 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 124 (17.44) | 18.7374 |
| 1990's | 194 (27.29) | 18.2507 |
| 2000's | 198 (27.85) | 29.6817 |
| 2010's | 143 (20.11) | 24.3611 |
| 2020's | 52 (7.31) | 2.80 |
| Authors | Studies |
|---|---|
| Aljurf, M; Ayala, E; Fernandez, A; Iqbal, M; Keller, K; Kharfan-Dabaja, MA; Kumar, A; Murthy, H; Reljic, T; Yassine, F | 1 |
| Bader, P; Furniss, SJ; Grabe-Heyne, K; Henne, C; Hooker, DS; Toumi, M | 1 |
| Devine, SM; Geller, N; Giralt, S; Heslop, HE; Ho, VT; Horowitz, MM; Jones, RJ; Litzow, MR; Logan, B; Luznik, L; Mendizabal, A; Muffly, L; Nemecek, ER; O'Donnell, L; O'Reilly, RJ; Palencia, R; Pasquini, MC; Perales, MA; Schetelig, J; Shune, L; Soiffer, RJ; Solomon, SR; Vasu, S; Wu, J | 1 |
| Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
| Barker, J; Brown, S; Castro-Malaspina, H; DeRespiris, L; Devlin, S; Giralt, SA; Gyurkocza, B; Jakubowski, AA; Lin, A; Maloy, M; Papadopoulos, EB; Perales, MA; Proli, A; Ruiz, JD; Sauter, CS; Shaffer, B; Tamari, R | 1 |
| Babushok, DV; Carulli, A; Frey, NV; Freyer, CW; Gill, SI; Hatch, RV; Hexner, EO; Loren, AW; Luger, SM; Martin, ME; McCurdy, SR; Perl, AE; Porter, DL; Pratz, KW; Redline, G; Stadtmauer, EA | 1 |
| Eckhaus, MA; Fletcher, RE; Hadjis, AD; Kanakry, CG; Khan, SM; Nunes, NS; Pohl, AP; Venzon, DJ | 1 |
| Aotsuka, N; Atsuta, Y; Eto, T; Hamamura, A; Hirayama, M; Ichinohe, T; Iemura, T; Kanaya, M; Kawakita, T; Kimura, T; Kondo, T; Kozai, Y; Morishima, S; Onizuka, M; Ozawa, Y; Sugio, Y; Takada, S; Takahashi, S; Tanaka, M; Uchida, N; Wake, A; Yamasaki, S; Yanada, M; Yokoyama, H | 1 |
| Burns, LJ; Cutler, C; Divine, C; Hamilton, BK; Horowitz, M; Juckett, M; Khera, N; LeMaistre, C; Stewart, S; Wilder, J | 1 |
| Docampo Simón, A; Espiñeira Sicre, J; Silvestre Salvador, JF | 1 |
| Bajel, A; Barmanray, RD; Collins, J; Hillman, M; Lim, ABM; Mason, K; Ramanan, R; Ritchie, D; Szer, J; Tan, JLC | 1 |
| Beitinjaneh, A; Brown, S; Chinapen, S; Devlin, S; Goodman, M; Jimenez Jimenez, A; Komanduri, K; Lekakis, L; Perales, MA; Pereira, D; Ponce, D; Sauter, C; Shaffer, BC; Wang, T | 1 |
| Al-Atrash, G; Alousi, AM; Bashir, Q; Champlin, RE; Hosing, CM; Kebriaei, P; Khouri, I; Mehta, RS; Nieto, Y; Oran, B; Popat, UR; Qazilbash, MH; Ramdial, J; Rezvani, K; Rondon, G; Saliba, RM; Shpall, EJ; Srour, SA | 1 |
| Kang, J; Kim, H; Kim, SI; Lim, KY; Park, JW; Park, SH; Shin, DY; Won, JK | 1 |
| Ishiguro, C; Kawashiri, A; Kurokawa, T; Maeda, Y; Mochizuki, K; Nakagawa, SI | 1 |
| Chen, C; Chen, K; Fu, B; Gong, S; He, X; Hu, J; Nie, L; Su, T; Wang, L; Xiao, H; Xu, Y; Yang, K; Yang, L; Yang, R; Zou, L | 1 |
| Bucher, C; Dertschnig, S; Finke, J; Gergely, P; Heim, D; Holler, E; Holtick, U; Medinger, M; Oehen, S; Passweg, J; Schanz, U; Socié, G; Stylianou, C; Teshima, T | 1 |
| Aoki, K; Arai, Y; Kanda, J; Kitawaki, T; Kondo, T; Mizumoto, C; Nakamura, N; Takaori-Kondo, A; Wada, F; Yamashita, K | 1 |
| Boeckh, MJ; Flowers, ME; Gooley, TA; Hill, GR; Mielcarek, MB; Sandmaier, BM; Ueda Oshima, M; Xie, H; Zamora, D | 1 |
| Hirabayashi, K; Maejima, Y; Maruyama, Y; Morokawa, H; Nakazawa, Y; Okura, E; Saito, S | 1 |
| Ayala, E; Brannick, KM; Foran, J; Iqbal, M; Kharfan-Dabaja, MA; Li, Z; Murthy, H; Nieto, FAM; Roy, V | 1 |
| Aichinger, C; Binder, M; Buxhofer-Ausch, V; Clausen, J; Hasengruber, P; Kaynak, E; Machherndl-Spandl, S; Milanov, R; Nikoloudis, A; Petzer, A; Stiefel, O; Strassl, I; Weltermann, A; Wipplinger, D | 1 |
| John, LS; Ma, Q; Molldrem, JJ; Sizova, O | 1 |
| Al Malki, MM; Alousi, AM; Applegate, K; Bhatt, AS; Bolaños-Meade, J; Clark, W; DiFronzo, NL; Efebera, YA; El Jurdi, N; Elmariah, H; Gooptu, M; Hall, AC; Hamadani, M; Holtan, SG; Horowitz, MM; Jamy, OH; Jones, RJ; Kean, LS; Larkin, KT; Leifer, E; Loren, AW; Martens, MJ; Perales, MA; Reshef, R; Rezvani, AR; Runaas, L; Shaffer, BC; Solh, M; Wu, J; Yao, JM | 1 |
| Brunstein, C; Copelan, EA; Corrigan, D; Dean, RM; Gerds, AT; Hamilton, BK; Hanna, R; Jagadeesh, D; Kalaycio, M; Li, H; Lucas, T; Majhail, NS; Rotz, SJ; Rybicki, LA; Sauter, CS; Sobecks, R | 1 |
| Abdel-Fattah, RM; El Gammal, MM; Elhaddad, AM; Maher, MA; Mahmoud, HK; Mansour, OM; Samra, MA; Shouman, MT | 1 |
| Futatsuki, T; Hikita, H; Imamura, Y; Inada, A; Kashiwazaki, H; Mizutani, S; Mori, Y; Oku, S | 1 |
| Alousi, AM; Bashir, Q; Champlin, RE; Hosing, C; Joseph, J; Kebriaei, P; Milton, DR; Olson, AL; Oran, B; Popat, UR; Qazilbash, MH; Ramdial, JL; Saini, NY; Shpall, EJ; Srour, SA | 1 |
| Goto, T; Julamanee, J; Kamoshita, S; Kiyoi, H; Koyama, D; Miyamura, K; Miyao, K; Murata, M; Nishida, T; Okuno, S; Ozawa, Y; Takagi, E; Terakura, S | 1 |
| Billick, M; Liu, J; Monsour, D; Wang, X | 1 |
| Fuji, S; Ishikawa, J; Kida, S; Koike, M; Masaie, H; Nakata, K; Nakata, R; Tada, Y; Tsutsumi, K; Yoshida, H | 1 |
| Behfar, M; Ghavamzadeh, A; Hamidieh, AA; Khodayari-Namini, N; Koochakzadeh, L; Rostami, T; Salajegheh, P; Yazdanian, N | 1 |
| Couban, S; Couture, F; Devins, G; Elemary, M; Foley, R; Gallagher, G; Kerr, H; Kuruvilla, J; Lee, SJ; Moore, J; Nevill, T; Panzarella, T; Popradi, G; Roy, J; Schultz, KR; Szwajcer, D; Toze, C; Walker, I | 1 |
| de Souza Durão Junior, M; Ferraz, FTP; Hamerschlak, N; Marra, AR | 1 |
| Estacio, M; Manzi, E; Medina, D; Rosales, M | 1 |
| Cai, C; Han, Y; Lv, X; Pan, T; Qi, J; Shi, B; Tang, Y; Zhou, M | 1 |
| Iwaki, N; Kurokawa, T; Maeda, Y; Mochizuki, K; Ozaki, J | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Haghighat, S; Haghighinejad, H; Namdari, N; Ramzi, M | 1 |
| Amit, O; Pasvolsky, O; Pek, A; Raanani, P; Ram, R; Rozovski, U; Rubinstein, M; Sela-Navon, M; Shargian-Alon, L; Wolach, O; Yeshurun, M; Zuckerman, T | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Yerushalmi, R | 1 |
| Beck, V; Forchhammer, S; Maier, CP; Walz, B | 1 |
| Dahllöf, G; Garming Legert, K; Mattsson, J; Remberger, M; Ringdén, O; Törlén, J | 1 |
| Atsuta, Y; Ichinohe, T; Iida, H; Katayama, Y; Kato, J; Miyamoto, T; Mori, T; Onishi, Y; Onizuka, M; Ota, S; Ozawa, Y; Shingai, N; Takenaka, K; Uchida, N; Yamaguchi, H; Yamazaki, H; Yoshioka, S | 1 |
| Ahmed, P; Ansar, I; Anwer, F; Ashraf, R; Chaudhry, QUN; Farhan, M; Ghafoor, T; Iftikhar, R; Khan, M; Khan, MA; Khattak, TA; Mahmood, SK; Marsh, J; Neupane, K; Rafae, A; Rehman, J; Satti, TM; Shahbaz, N; Shamshad, GU | 1 |
| Araie, H; Goto, M; Goto, T; Ichiki, T; Kawaguchi, Y; Lee, Y; Miyamura, K; Morishita, T; Ohbiki, M; Okabe, M; Osaki, M; Ozawa, Y | 1 |
| Heo, BY; Jo, DY; Kwon, J; Lee, HJ; Lee, MW; Ryu, H; Song, IC; Yeon, SH; Yun, HJ | 1 |
| Buizen, L; Butler, JP; Chang, K; Cooney, J; Curley, C; Durrant, S; Gartlan, KH; Gottlieb, D; Henden, AS; Hill, GR; Kennedy, GA; Misra, A; Moore, J; Morton, AJ; Olver, SD; Paul, SK; Ritchie, D; Subramoniapillai, E; Tey, SK; Varelias, A | 1 |
| Atsuta, Y; Fukuda, T; Ichinohe, T; Katsuoka, Y; Kawakita, T; Kimura, T; Kouzai, Y; Kuwatsuka, Y; Morishige, S; Murata, M; Najima, Y; Nakamae, H; Ozawa, Y; Ozeki, K; Sakaida, E; Sawa, M; Sugita, J; Takahashi, S; Terakura, S; Teshima, T; Yoshioka, S | 1 |
| Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Matsuoka, KI | 1 |
| AlJohani, NI | 1 |
| Anasetti, C; Ayala, E; Betts, B; Chen, L; Dean, E; Fernandez, H; Kharfan-Dabaja, M; Khimani, F; Kim, J; Locke, F; Mishra, A; Nieder, M; Nishihori, T; Perez, L; Pidala, J; Rizk, V | 1 |
| Ahn, KW; Atallah, E; Boyd, J; Bunner, P; Carlson, KS; Craig, M; Cumpston, A; D'Souza, A; Drobyski, W; Fenske, TS; Guru Murthy, GS; Hamadani, M; Hari, PN; Horowitz, MM; Kanate, AS; Michaelis, L; Pasquini, MC; Rizzo, JD; Saber, W; Visotcky, A | 1 |
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Cho, BS; Cho, SG; Eom, KS; Jeon, YW; Kim, DW; Kim, HJ; Kim, YJ; Kwak, DH; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Park, SS; Yoon, JH | 1 |
| Bertz, H; Bethge, WA; Finke, J; Grishina, O; Heim, D; Ottinger, H; Schmoor, C; Socie, G; Stelljes, M; Volin, L | 1 |
| D'Souza, A; Lee, S; Pasquini, M; Zhu, X | 1 |
| Arnold, DE; Bunin, NJ; Elgarten, CW; Seif, AE | 1 |
| Braun, T; Choi, SW; Dinarello, CA; Gatza, E; Henig, I; Magenau, J; Parkin, B; Pawarode, A; Reddy, P; Riwes, M; Yanik, G | 1 |
| Alyea, EP; Artz, A; Boyer, MW; Chen, YB; DiPersio, JF; Gergis, U; Glavin, F; Ho, VT; Holter, J; Horwitz, ME; Jagasia, MH; Johnston, L; Kim, HT; Levine, JD; Lewis, ID; Martin, PJ; Maziarz, RT; McGuirk, J; Patnaik, MM; Pidala, JA; Porter, DL; Reshef, R; Ritz, J; Rybka, W; Safah, H; Shaughnessy, PJ; Shea, TC; Soiffer, RJ; Stiff, PJ; Szer, J; Vusirikala, M; Westervelt, P | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| D'Souza, A; Drobyski, WR; Dunn, R; Eapen, M; Fenske, TS; Hamadani, M; Hari, P; Hebert, KM; Horowitz, MM; Johnson, B; Keever-Taylor, C; Pasquini, M; Rizzo, JD; Saber, W; Shah, N; Shaw, B; Szabo, A; Yim, S; Zhu, F | 1 |
| Ikeda, K; Ito, M; Kikuta, A; Kobayashi, S; Mochizuki, K; Ohara, Y; Ohto, H; Sano, H; Takahashi, N; Waragai, T | 1 |
| Cooper, D; DeVeaux, M; Foss, F; Isufi, I; Kim, TK; Perreault, S; Seropian, S; Shlomchik, W; Stahl, M; Zeidan, AM; Zelterman, D | 1 |
| Akahane, D; Gotoh, M; Kobayashi, C; Ohyashiki, JH; Ohyashiki, K; Saitoh, Y; Umezu, T; Yoshizawa, S | 1 |
| Abdel-Azim, H; Aljurf, MD; Alousi, AM; Antin, JH; Arora, M; Cahn, JY; Chhabra, S; Cooper, B; Costa, L; Couriel, DR; Gale, RP; Gergis, U; Hamilton, BK; Hashmi, SK; Hayashi, RJ; Hematti, P; Hemmer, MT; Inamoto, Y; Kamble, RT; Kim, D; Lehmann, L; Litzow, MR; Liu, Y; MacMillan, ML; Majhail, NS; Marks, DI; Martino, R; Nishihori, T; Pidala, JA; Qayed, M; Ringden, O; Saad, A; Savani, BN; Schoemans, H; Schouten, HC; Seo, S; Socie, G; Solh, MM; Spellman, SR; Stuart, RK; Teshima, T; Urbano-Ispizua, A; Verdonck, LF; Vij, R; Wagner, J; Yared, J | 1 |
| Bolwell, B; Corrigan, D; Dean, R; Dumont, C; Figueroa, P; Gerds, AT; Hamilton, BK; Hanna, R; Hill, B; Jagadeesh, D; Kalaycio, M; Liu, H; Lu, W; Majhail, NS; Patel, SS; Pohlman, B; Ricci, K; Rybicki, LA; Sobecks, R | 1 |
| Fukushima, T; Hosaka, S; Imadome, KI; Imai-Saito, A; Iwabuchi, A; Jimbo, T; Kato, Y; Kobayashi, C; Kosaki, K; Masumoto, K; Nanmoku, T; Onodera, M; Saito, H; Sumazaki, R; Suzuki, R; Takada, H; Watanabe, N | 1 |
| Li, S; Liao, YX; Liu, XO; Miao, WJ; Tian, JX; Wang, XD; Yan, HH; Zhang, P | 1 |
| Chen, M; He, X; Huang, B; Lin, X; Zhang, Y; Zhang, Z; Zheng, Z; Zhong, C | 1 |
| Beato Merino, MJ; Gómez-Fernández, C; Hernández-Maraver, D; Herranz Pinto, P; Maldonado Cid, P; Noguera Morel, L; Sendagorta Cudós, E | 1 |
| Dalton, JT; Devine, SM; Edwards, RB; Farag, SS; Grever, MR; Hofmeister, CC; Jansak, BS; Johnston, JS; Lucas, DM; Phelps, MA; Poi, MJ | 1 |
| Bosch, MM; Goldblum, D; Halter, JP; Sabti, S | 1 |
| Boyer, J; Frey, NV; Goldstein, SC; Hexner, EO; June, CH; Kumar, AJ; Levine, BL; Loren, AW; Luger, SM; Porter, DL; Reshef, R; Smith, J; Stadtmauer, EA | 1 |
| Abdel-Rahman, F; Adil, SN; Ahmed, P; Alabdulaaly, A; Alimoghaddam, K; Aljurf, M; Alseraihy, A; Bazarbachi, A; Bekadja, MA; Ben Othman, T; Benchekroun, S; Dennison, D; Elhaddad, A; Ghavamzadeh, A; Hamidieh, A; Hamladji, R; Hussain, F; Ibrahim, A; Jarrar, M; Mohamed, SY; Ramzi, M; Rasheed, W | 1 |
| Andresen, S; Bolwell, B; Copelan, E; Dean, R; Duong, H; Hamilton, BK; Hanna, R; Hill, B; Kalaycio, M; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| McNeil, C | 1 |
| Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X | 1 |
| Fukano, R; Inagaki, J; Kodama, Y; Nishimura, M; Okamura, J; Shimokawa, M | 1 |
| Abrams, S; Chen, GL; Hahn, T; Liu, H; McCarthy, PL; Ross, M; Zhang, Y | 1 |
| Askar, M; Mossad, S; Rybicki, L; Sobecks, R; Taimur, S; Warshawsky, I | 1 |
| Gafter-Gvili, A; Ram, R; Shpilberg, O; Vidal, L; Yeshurun, M | 1 |
| Fujisaki, H; Hara, J; Nakano, Y; Okada, K; Osugi, Y; Tanaka, C; Yamasaki, K | 1 |
| Barnes, Y; Borowitz, M; Bunin, N; Carroll, WL; Douglas, JG; Gardner, S; Gastier-Foster, JM; Goyal, RK; Grupp, SA; Howrie, D; Langholz, B; Pulsipher, MA; Raetz, E; Schultz, KR; Taylor, C; Teachey, DT; Wall, DA | 1 |
| Alberca, I; Caballero, D; Cabrero-Calvo, M; Del Cañizo, MC; Díez-Campelo, M; González-Porras, JR; Guerrero, C; Labrador, J; López-Corral, L; López-Godino, O; Pérez-López, E; Pérez-López, R; Pérez-Simón, JA; Sánchez-Guijo, F; Vázquez, L | 1 |
| Bhattacharya, R; Biswas, A; Park, E | 1 |
| Barker, JN; Castro-Malaspina, H; Ceberio, I; Devlin, SM; Giralt, S; Goldberg, JD; Lechner, L; Maloy, MA; Perales, MA; Ponce, DM; Sauter, C | 1 |
| Dahan, D; Dreyer, J; Herscovici, C; Israeli, M; Peck, A; Ram, R; Shpilberg, O; Yeshurun, M | 1 |
| Antin, JH; Carter, SL; Choi, S; Cutler, C; Grupp, S; Hogan, WJ; Horowitz, MM; Hsu, JW; Hu, ZH; Johnston, L; Logan, B; MacMillan, ML; McCarthy, P; Nakamura, R; Pasquini, M; Porter, D; Waller, EK; Wu, J | 1 |
| Djulbegovic, B; Kharfan-Dabaja, M; Kumar, A; Mhaskar, R; Perkins, JB; Pidala, J; Reljic, T | 1 |
| de Lima, M; William, BM | 1 |
| Chen, YH; Hou, J; Hu, DM; Huang, XJ; Jiang, M; Lai, YR; Li, QC; Liu, KY; Liu, L; Liu, QF; Schwarzenberger, P; Zhang, ZM | 1 |
| Chen, T; Du, Q; Huang, Y; Lin, X; Lu, Z; Song, C; Sun, C; Tao, Y; Tu, S; Wu, B | 1 |
| Baker, KS; Burroughs, LM; Deeg, HJ; Delaney, C; Domm, J; Englund, JA; Flowers, ME; Giller, RH; Nemecek, ER; Rawlings, DJ; Shimamura, A; Skoda-Smith, S; Storb, R; Storer, BE; Talano, JA; Thakar, MS; Torgerson, TR; Woolfrey, AE | 1 |
| Cho, BS; Cho, SG; Eom, KS; Jeon, YW; Kim, DW; Kim, HJ; Kim, JH; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Park, CW; Shin, SH; Yahng, SA; Yoon, JH | 1 |
| Adachi, S; Atsuta, Y; Azuma, E; Chin, M; Goto, H; Hatakeyama, N; Hyakuna, N; Igarashi, S; Inoue, M; Kato, K; Koh, K; Kudo, K; Murata, M; Ogawa, A; Ohshima, K; Sakata, N; Sawada, A; Takahashi, Y; Takami, A; Tanaka, S; Umeda, K | 1 |
| Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y; Zhu, F | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
| Fukano, R; Inagaki, J; Kodama, Y; Noguchi, M; Okamura, J | 1 |
| Beck, J; Gruhn, B; Steinbach, D; Weiss, M; Zintl, F | 1 |
| Hasegawa, D; Iwata, A; Kawaguch, K; Kobayashi, M; Kosaka, Y; Matsubara, K; Miyata, K; Nigami, H; Saito, A; Uchida, Y | 1 |
| Champlin, RE; Eapen, M; Horowitz, MM; Lee, SJ; Logan, BR; Perales, MA; Rocha, V; Soiffer, RJ; Zhong, X | 1 |
| Chen, F; Chen, S; Fu, Z; Han, Y; Jin, S; Jin, Z; Liu, L; Ma, X; Miao, M; Qiu, H; Sun, A; Tang, X; Wang, X; Wu, D; Zhang, X | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Bollard, C; Cuellar-Rodriguez, J; Freeman, AF; Gea-Banacloche, J; Grossman, J; Hickstein, DD; Holland, SM; Kong, HH; Moutsopoulos, N; Murdock, H; Parta, M; Shah, N; Stone, K; Su, H | 1 |
| Anasetti, C; Ayala, E; Figueroa, J; Kharfan-Dabaja, MA; Kim, J; Locke, F; Nishihori, T; Perkins, J; Riches, M; Yue, B | 1 |
| Anasetti, C; Beato, F; Betts, BC; Kim, J; Lawrence, HR; Lloyd, MC; Pidala, J; Sagatys, EM; Sebti, SM; Veerapathran, A; Yue, B | 1 |
| Gao, YT; Qian, LL; Shen, JP; Wen, XW; Ye, BD; Zhang, Y; Zhou, YH | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Betts, BC; Fernandez, HF; Field, T; Jim, H; Kharfan-Dabaja, MA; Kim, J; Locke, FL; Mishra, A; Nishihori, T; Ochoa-Bayona, L; Perez, L; Pidala, J; Riches, M | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, FR; Wang, JZ; Wang, Y; Xu, LP; Yan, CH | 1 |
| Abramson, J; Antin, JH; Armand, P; Barnes, J; Brown, J; Chen, YB; Cutler, C; Del Rio, C; Driscoll, J; El-Jawahri, A; Fisher, DC; Ho, VT; Hochberg, E; Jacobsen, E; Li, S; McAfee, S; Soiffer, R; Spitzer, TR; Takvorian, R | 1 |
| Akpek, G; Alousi, AM; Antin, JH; Arora, M; Cairo, MS; Chao, NJ; Couriel, DR; Cutler, CS; Flowers, ME; Gale, RP; Gupta, V; Hamilton, BK; Hayashi, RJ; Hemmer, MT; Inamoto, Y; Kharfan-Dabaja, MA; Marks, DI; Martin, PJ; Nishihori, T; Reshef, R; Ringdén, OT; Saad, A; Shah, A; Socié, G; Solh, MM; Spellman, SR; Tallman, MS; Teshima, T; Urbano-Ispizua, A; Wang, T; Wirk, B | 1 |
| Dreyer, J; Gruenewald, T; Herscovici, C; Israeli, M; Levy-Assaraf, M; Mechoulam, R; Peck, A; Raanani, P; Ram, R; Shargian, L; Shpilberg, O; Yeshurun, M | 1 |
| Alyea, EP; Antin, JH; Armand, P; Bindra, B; Blazar, BR; Chammas, MJ; Cutler, CS; Glotzbecker, B; Ho, VT; Kim, HT; Koreth, J; Lange, PB; Nikiforow, S; Reynolds, CG; Ritz, J; Soiffer, RJ | 1 |
| Afanasyev, B; Al Seraihy, A; Aljurf, M; Ancliff, P; Bierings, M; Calvillo, M; de Wreede, L; Donadieu, J; Dufour, C; Fioredda, F; Fischer, A; Ganser, A; Gaspar, B; Iacobelli, S; Kalwak, K; Ljungman, P; Marsh, J; Matthes-Martin, S; Morreale, G; Or, R; Ozturk, G; Peffault de Latour, R; Peters, C; Sánchez de Toledo Codina, J; Smith, O; van 't Veer-Tazelaar, N; van Biezen, A; Veys, P; Wynn, R; Yesilipek, A | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Haddad, H; Hamilton, BK; Hanna, R; Hill, B; Kalaycio, M; Liu, H; Majhail, NS; Rybicki, L; Sobecks, R; Yurch, M | 1 |
| Bruce, AJ; Chaudhry, HM; Hashmi, SK; Hogan, WJ; Kremers, WK; Litzow, MR; Patnaik, MS; Phillips, GL; Wolf, RC | 1 |
| Murata, M | 1 |
| Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L | 1 |
| Ariga, T; Cho, Y; Iguchi, A; Kobayashi, R; Ohshima, J; Sato, TZ; Sugiyama, M; Terashita, Y | 1 |
| Alyea, EP; Blum, W; Carter, S; Champlin, RE; Chen, YB; Devine, SM; Giralt, S; Hars, V; Horowitz, MM; Hsu, JW; Larson, RA; Linker, C; Mulkey, F; Owzar, K; Shea, TC; Sibley, AB; Slack, J; Soiffer, RJ; Stone, RM; Vij, R | 1 |
| Agematsu, K; Amano, Y; Inaba, Y; Kobayashi, N; Koike, K; Kurata, T; Motobayashi, M; Nakazawa, Y; Shigemura, T; Tanaka, M | 1 |
| Betz, KM; Blazar, BR; Bosinger, SE; Chen, J; Cooley, S; Flynn, R; Furlan, SN; Garrett, A; Giver, C; Hamby, K; Kean, LS; Miller, JS; Promislow, DE; Ramakrishnan, S; Singh, K; Stempora, L; Tharp, GK; Tkachev, V; Waller, EK; Watkins, B; Ziegler, CG | 1 |
| Müller, LP; Müller-Tidow, C; Niestadtkötter, J; Weber, T; Wienke, A | 1 |
| Cho, YH; Kim, AR; Kim, SY; Lee, MH; Yoon, SY | 1 |
| Frey, NV; Ganetsky, A; He, J; Hexner, EO; Hwang, WT; Loren, AW; Miano, TA; Porter, DL; Reshef, R; Shah, A | 1 |
| Lazarevic, VLj | 1 |
| Alyea, EP; Antin, JH; Armand, P; Bachanova, V; Chen, YB; Cutler, C; Devine, SM; Giardino, AA; Herrera, AF; Ho, VT; Jagirdar, N; Kim, HT; Koreth, J; Lange, PB; McAfee, SL; Sainvil, MM; Soiffer, RJ; Waller, EK | 1 |
| Andritsos, L; Auletta, JJ; Benson, DM; Bingman, A; Blum, W; Bradbury, H; Devine, SM; Efebera, Y; Elder, P; Geyer, S; Hofmeister, C; Jaglowski, S; Kitzler, R; Klisovic, R; Lozanski, G; Muthusamy, N; O'Donnell, LC; Penza, S; Vasu, S | 1 |
| Chang, W; Chen, F; Fu, C; Jin, Z; Ma, X; Miao, M; Qiu, H; Ruan, C; Sun, A; Tang, X; Wu, D; Xue, S | 1 |
| Adachi, S; Ago, H; Atsuta, Y; Eto, T; Fukuda, T; Iwato, K; Kanamori, H; Kobayashi, N; Miyamura, K; Mori, T; Morishima, Y; Morita, S; Murata, M; Nagamura-Inoue, T; Ohashi, K; Oshima, K; Sakai, R; Sakamaki, H; Taguri, M; Taniguchi, S | 1 |
| Endo, T; Fujimoto, K; Goto, H; Hashimoto, D; Hashino, S; Kahata, K; Kashiwazaki, H; Kondo, T; Matsukawa, T; Matsushita, T; Nakazawa, S; Onozawa, M; Sugita, J; Teshima, T; Yamazaki, Y | 1 |
| Arai, N; Ariizumi, H; Fujiwara, S; Hattori, N; Kabasawa, N; Kawaguchi, Y; Nakamaki, T; Saito, B; Tsukamoto, H; Uto, Y; Yamamoto, K; Yanagisawa, K | 1 |
| Chinratanalab, W; Engelhardt, BG; Goodman, SA; Greer, JP; Jagasia, M; Kassim, AA; Kennedy, VE; Savani, BN; Sengsayadeth, S | 1 |
| Garming-Legert, K; Itälä-Remes, M; Ljungman, P; Mattsson, J; Remberger, M; Remes, K; Ringdén, O; Törlén, J; Winiarski, J | 1 |
| Byun, JM; Kim, HL; Kim, I; Kim, JH; Koh, Y; Lee, YG; Park, SS; Seong, MW; Shin, DY; Yoon, SS | 1 |
| Abu Zaid, M; Antin, JH; Choi, SW; Cutler, C; Logan, BR; Paczesny, S; Wu, C; Wu, J; Yu, J | 1 |
| Atsuta, Y; Fukuda, T; Ichinohe, T; Inamoto, Y; Kanamori, H; Murata, M; Ohashi, K; Onishi, Y; Ozawa, Y; Sakai, R; Takahashi, S; Takanashi, M; Terakura, S; Teshima, T; Uchida, N; Wake, A; Yamaguchi, H; Yamaguchi, T | 1 |
| Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
| Anasetti, C; Ayala, E; Beato, F; Fernandez, H; Neuger, A; Perez, LE; Pidala, J; Schell, MJ | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Shouval, R; Yerushalmi, R | 1 |
| Campos-Castro, A; Leon-Rodriguez, E; Rivera-Franco, MM | 1 |
| Aljurf, M; Bacher, U; Beitinjaneh, A; Chen, YB; de Lima, M; DeFilipp, Z; Gale, RP; Gupta, V; Kebriaei, P; Kharfan-Dabaja, M; Khoury, HJ; Lazarus, HM; Michelis, FV; Nishihori, T; Olsson, RF; Oran, B; Rashidi, A; Rizzieri, DA; Saber, W; Sandmaier, BM; Tallman, MS; Wang, HL; Weisdorf, D; Zhang, MJ | 1 |
| Adil, S; Ahmed, P; Ansari, S; Farzana, T; Hashmi, K; Irfan, M; Khan, B; Panjwani, V; Shamsi, T | 1 |
| Arat, M; Dalva, K; Soydan, E; Topcuoglu, P | 1 |
| Bhurani, D; Kerridge, I; Schifter, M | 1 |
| Alyea, EP; Antin, JH; Cutler, C; Ho, V; Kim, HT; Li, S; Soiffer, RJ | 1 |
| Cai, Z; Deng, D; Lai, Y; Li, Q; Li, W; Liang, J; Luo, J; Luo, L; Ma, J; Peng, Z; Schwarzenberger, P; Yang, J; Zhou, J; Zhou, Y | 1 |
| Hara, J; Hashii, Y; Kusuki, S; Ohta, H; Ozono, K; Sakai, N; Takizawa, S; Taniike, M; Tokimasa, S | 1 |
| Kanda, Y | 1 |
| Gafter-Gvili, A; Paul, M; Raanani, P; Ram, R; Shpilberg, O; Yeshurun, M | 1 |
| Alyea, EP; Antin, JH; Armand, P; Brown, JR; Canellos, GP; Cutler, CS; Fisher, DC; Freedman, AS; Gannamaneni, S; Ho, VT; Jacobsen, ED; Kim, HT; Koreth, J; LaCasce, AS; Soiffer, RJ | 1 |
| Horibe, K; Kato, K; Kojima, S; Matsumoto, K; Matsuyama, T; Watanabe, N; Yoshimi, A | 1 |
| Atsuta, Y; Hara, M; Hirai, H; Kanamori, H; Kodera, Y; Matsuo, K; Morishima, Y; Murayama, T; Nishida, T; Okamoto, S; Sao, H | 1 |
| Fujiwara, T; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Miyamura, K; Ohguchi, H; Okitsu, Y; Tomiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H | 1 |
| Gourde, JA; Khan, SP; Rodriguez, V; Sabapathy, C | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Moreno, E; Piñana, JL; Sierra, J; Sureda, A; Valcárcel, D; Vega, M | 1 |
| Gratwohl, A | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, Y; Xu, LP | 1 |
| Hishizawa, M; Hori, T; Ichinohe, T; Imada, K; Ishikawa, T; Kadowaki, N; Kanda, J; Kawabata, H; Kondo, T; Matsui, M; Mizumoto, C; Nishikori, M; Takaori-Kondo, A; Uchiyama, T; Yamashita, K | 1 |
| Cho, BS; Cho, SG; Eom, KS; Jin, JY; Kim, CC; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Min, CK; Min, WS | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Aldridge, J; Alyea, EP; Antin, JH; Armand, P; Cutler, C; Ho, VT; Kim, HT; Koreth, J; Soiffer, RJ | 1 |
| Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 2 |
| Alyea, EP; Antin, JH; Armand, P; Cutler, C; Garcia, M; Ho, VT; Kim, HT; Koreth, J; Ritz, J; Soiffer, RJ; Stevenson, KE | 1 |
| Mehta, J | 1 |
| Al-Ghamdi, A; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Ayas, M; Chaudhri, N; Mohammed, SY; Nassar, A; Tabbara, KF | 1 |
| Boucher, KM; Bunin, N; Goyal, RK; Grimley, M; Grupp, SA; Hankins, P; Pulsipher, MA; Wall, DA | 1 |
| Forman, SJ; Gaal, K; Nakamura, R; Palmer, J; Pullarkat, V; Sahebi, F; Snyder, DS; Stein, AS; Vora, N | 1 |
| Andritsos, L; Bechtel, T; Benson, DM; Blum, W; Byrd, JC; Devine, SM; Elder, P; Garzon, R; Hamadani, M; Hofmeister, C; Klisovic, R; Krugh, D; Lin, T; Marcucci, G; O'Donnell, L; Penza, S; Phillips, G | 1 |
| Antin, JH; Cutler, C; Storb, R | 1 |
| Kato, K; Kato, S; Kawase, T; Kigasawa, H; Kodera, Y; Kojima, S; Morishima, Y; Muramatsu, H; Sakamaki, H; Tsuchida, M; Yabe, H; Yagasaki, H | 1 |
| Chang, YJ; Huang, XJ; Huo, MR; Liu, DH; Liu, KY; Xu, LP; Zhao, XY | 1 |
| Hassan, Z; Mattsson, J; Olsson, R; Omazic, B; Remberger, M; Ringdén, O | 1 |
| Grigg, AP; Hoyt, R; Ritchie, DS; Szer, J; Wirth, A | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Fernandez, H; Field, T; Janssen, W; Kharfan-Dabaja, MA; Kim, J; Ochoa, L; Perez, L; Perkins, J; Sullivan, D; Xu, M | 1 |
| Barba, P; Brunet, S; Carreras, E; Fernández-Avilés, F; Martínez, C; Martino, R; Piñana, JL; Rovira, M; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Ashouri, A; Babaie, MH; Ghavamzadeh, A; Iravani, M; Khatami, F; Tavakoli, E | 1 |
| Acholonu, S; Champlin, R; Dabaja, B; Donato, M; Duvic, M; Hosing, C; Khouri, I; Richmond, H; Singh, L; Wei, W | 1 |
| Cao, YB; Da, WM; Gao, CJ; Li, HH; Li, XH; Ma, J; Wu, XX; Yu, L | 1 |
| Fukuhara, N; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Ohba-Ohtsuka, R; Ohguchi, H; Ohnishi, Y; Okitsu, Y; Tohmiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H | 1 |
| Kagaya, H; Miura, M; Nara, M; Saitoh, H; Sawada, K; Takahashi, N | 1 |
| Boiron, JM; Bouabdallah, K; Coiffard, J; Dilhuydy, MS; Lafarge, X; Leguay, T; Marit, G; Melot, C; Milpied, N; Pigneux, A; Schmitt, A; Tabrizi, R; Vigouroux, S | 1 |
| Gooley, TA; Kiem, HP; Sale, G; Sandmaier, BM; Santos, EB; Storb, R; Thakar, MS | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, J; Wang, Y; Xu, LP | 2 |
| Ahmed, S; Al-Anazi, K; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Bakr, M; Chaudhri, N; Elhassan, T; Elkum, N; Hussain, F; Ibrahim, K; Mohamed, S; Nassar, A; Nurgat, Z; Patel, M; Rasheed, W; Saleh, AJ | 1 |
| Abdelqader, S; Abonour, R; Baute, J; Cornetta, K; Farag, SS; Fausel, CA; Kalsekar, I; Kiel, PJ; Nelson, RP; Robertson, MJ; Rosenbeck, LL; Schwartz, J; Srivastava, S; Sullivan, CK; Vargo, C; Wood, L | 1 |
| Bredeson, C; Ewell, M; Goodman, SA; Horowitz, MM; Kahl, BS; Laport, GG; Negrin, RS; Tomblyn, MR; Vose, JM | 1 |
| Alousi, A; Anderlini, P; Andersson, BS; Berry, D; Bosque, D; Cano, P; Champlin, RE; Couriel, D; de Lima, MJ; Fernandez-Vina, M; Giralt, S; Hosing, C; Jones, RB; Munsell, MF; Parmar, S; Popat, U; Shpall, EJ; Silva, Lde P; Wathen, JK; Westmoreland, M | 1 |
| Bauer, K; Engert, A; Kluge, S; Kreuzer, KA; Monsef, I; Siebert, H; Skoetz, N | 1 |
| Chun, C; Fang, JP; Huang, K; Huang, SL; Xu, HG; Xue, HM; Zhou, DH | 1 |
| Adorno, G; Alfieri, C; Andreani, M; Daniele, N; De Angelis, G; Del Proposto, G; Gallucci, C; Gaziev, J; Isgrò, A; Lanti, A; Lucarelli, G; Marziali, M; Paciaroni, K; Roveda, A; Saltarelli, F; Simone, MD; Sodani, P; Testi, M | 1 |
| Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Di Nicola, M; Fernandez, H; Field, T; Janssen, W; Kharfan-Dabaja, MA; Ochoa, L; Perez, L; Perkins, J; Pidala, J; Raychaudhuri, J; Santarone, S | 1 |
| Baricordi, OR; Bellesi, S; Chiusolo, P; De Ritis, D; Giammarco, S; Leone, G; Marietti, S; Metafuni, E; Piccirillo, N; Rizzo, R; Sica, S; Stignani, M | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Flowers, ME; Furlong, T; Inamoto, Y; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, RF; Storer, BE; Witherspoon, RP | 1 |
| Asaka, M; Endo, T; Fujimoto, K; Hashino, S; Ibata, M; Imamura, M; Kashiwazaki, H; Kondo, T; Kosugi, M; Matsushita, T; Nishio, M; Obara, M; Shigematsu, A; Shiratori, S; Shono, Y; Sugita, J; Takahashi, S; Tanaka, J; Wakasa, K | 1 |
| Djulbegovic, B; Hozo, I; Kumar, A; Miladinovic, B | 1 |
| Antin, JH | 1 |
| Azuma, H; Hara, J; Isoyama, K; Ito, E; Kai, S; Kato, K; Kato, S; Kikuchi, A; Kobayashi, R; Nagamura-Inoue, T; Nagatoshi, Y; Oki, K; Takanashi, M; Yoshimi, A | 1 |
| Aisa, Y; Kato, J; Kunimoto, H; Mori, T; Nakazato, T; Okamoto, S; Ono, Y; Shimizu, T; Yamane, A | 1 |
| Cheng, J; Ding, JH; Liu, J; Wang, J; Wu, F; Yu, ZP; Zhao, G | 1 |
| Clifford, R; Danby, R; Ellis, A; Hatton, C; Littlewood, T; Malladi, R; Medd, P; Monk, I; Peniket, A; Roberts, D; Vyas, P | 1 |
| Bardy, P; Diviney, M; Grigg, A; Holdsworth, R; Hoyt, R; King-Kallimanis, B; McCluskey, J; Murphy, NM; Szer, J; Tait, BD | 1 |
| Akashi, K; Fukagawa, S; Furue, M; Miyamoto, T; Moroi, Y; Sugiyama, A; Takeuchi, S; Yoshimoto, G | 1 |
| Busemann, C; Dölken, G; Kiefer, T; Krüger, WH; Neumann, T; Wilfert, H | 1 |
| Cannell, P; Cooney, J; Herrmann, R; Phillips, M; Purtill, D; Shaw, K; Sturm, M; Wright, M | 1 |
| Bajwa, RP; Garee, A; Gross, TG; Pai, V; Skeens, M; Soni, S; Termuhlen, AM | 1 |
| Katayama, Y; Matsui, T; Minagawa, K; Yamamori, M | 1 |
| Burton, L; Chiuzan, C; Garrett-Mayer, E; Heath, TS; Hudspeth, MP; Nista, E; Ragucci, D | 1 |
| Alsina, M; Anasetti, C; Ayala, E; Betts, BC; Fernandez, HF; Field, T; Janssen, WE; Jim, H; Kharfan-Dabaja, MA; Kim, J; Locke, FL; Nishihori, T; Ochoa, L; Perez, L; Perkins, J; Pidala, J; Tomblyn, M; Veerapathran, A; Xu, M | 1 |
| Aoki, J; Doki, N; Honda, A; Kakihana, K; Kobayashi, T; Ohashi, K; Sakamaki, H | 1 |
| Choi, B; Han, N; Kim, IW; Lee, ES; Oh, JM; Park, SY; Yun, HY | 1 |
| Alyea, EP; Antin, JH; Armand, P; Bindra, B; Blazar, BR; Cutler, C; Ho, VT; Kim, HT; Koreth, J; McDonough, SM; Ritz, J; Soiffer, RJ; Stevenson, KE | 1 |
| Dahllöf, G; Garming-Legert, K; Karlsson, H; Mattsson, J; Remberger, M; Ringdén, O; Svenberg, P; Uhlin, M; Uzunel, M | 1 |
| Bucher, CM; Passweg, JR | 1 |
| Fujisawa, S; Fujita, H; Kanamori, H; Kanda, Y; Kobayashi, T; Mori, T; Nakaseko, C; Nannya, Y; Ohashi, K; Okamoto, S; Sakamaki, H; Sakura, T; Takahashi, S; Tanaka, M; Yokota, A | 1 |
| Gao, YQ; Sun, RJ; Sun, Y; Wei, ZJ; Xiao, J; Zhang, YC; Zhu, HL | 1 |
| Fu, J; Huang, H; Lin, M; Zhang, R; Zheng, W | 1 |
| Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
| Chen, Y; Gao, Z; Guo, N; Huang, X; Lu, D; Ren, H; Xu, L; Zhang, Y | 1 |
| Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kim, EH; Murakami, M; Ogawa, H; Oji, Y; Oka, Y; Soma, T; Sugiyama, H; Tamaki, H; Tatekawa, T; Tsuboi, A | 1 |
| Chen, MG; Gastineau, DA; Gertz, MA; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A; Wolf, RC | 1 |
| Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
| Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
| Aschan, J; Barkholt, L; Eriksson, B; Hentschke, P; Holmberg, K; Myrbäck, KE; Remberger, M; Ringdén, O; Svahn, BM | 1 |
| Bonetti, F; Conter, V; Fagioli, F; Favre, C; Giorgiani, G; Lanino, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Rondelli, R; Sacchi, N; Uderzo, C; Zecca, M | 1 |
| Fischer, G; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Lechner, K; Mayr, W; Mitterbauer, M; Worel, N | 1 |
| Bernaudin, F; Blatt, J; Brichard, B; Brochstein, JA; Ertem, M; Garnier, F; Giorgiani, G; Gluckman, E; Grafakos, S; Haut, PR; Ionescu, I; Kurtzberg, J; Li, X; Locatelli, F; Lubin, BH; Lutz, P; Miniero, R; Nagler, A; Nugent, DJ; Raja, T; Reed, W; Roberts, I; Rocha, V; Rubin, CM; Tannoia, N; Vermylen, C; Walters, MC; Will, AM; Woodard, P; Yaniv, I | 1 |
| Aker, M; Bloom, AI; Nagler, A; Or, R; Resnick, IB; Sasson, T; Shapira, MY; Slavin, S; Verstanding, A; Zilberman, I | 1 |
| Ashihara, E; Fuchida, S; Fujita, N; Inaba, T; Maruya, E; Nakagawa, M; Ochiai, N; Okano, A; Shimazaki, C; Sumikuma, T | 1 |
| Ayuk, F; Erttmann, R; Horstmann, M; Kabisch, H; Kordes, U; Kröger, N; Krüger, W; Renges, H; Rischewski, J; Schrum, J; Zabelina, T; Zander, AR | 1 |
| Chen, HR; Ji, SQ; Liu, J; Wang, HX; Xue, M; Xun, CQ; Yan, HM; Zhu, L | 1 |
| Arcese, W; Bacigalupo, A; Bunjes, D; Frassoni, F; Gluckman, E; Koc, H; Labopin, M; Ringdén, O; Rocha, V; Schaefer, UW; Schattenberg, A; Willemze, R | 1 |
| Akaho, R; Akiyama, H; Hagiya, K; Mori, S; Nakagome, K; Sakamaki, H; Sasaki, T; Yoshino, M | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
| Flowers, ME; Leisenring, W; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Ju, XP; Li, HM; Song, XM; Tong, SP; Wang, JM; Zhang, WP | 1 |
| Alyea, EP; Antin, JH; Cutler, C; Ho, VT; Hochberg, EP; Kim, HT; Lee, SJ; Miklos, DB; Soiffer, RJ; Wu, CJ | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kawase, I; Kim, EH; Konaka, Y; Kunitomi, A; Masuda, T; Mukouchi, C; Murakami, M; Nishida, S; Ogawa, H; Oji, Y; Oka, Y; Sugiyama, H; Taniguchi, Y; Tsuboi, A | 1 |
| Kawano, Y; Koga, Y; Nagatoshi, Y; Okamura, J | 1 |
| Benner, A; Goerner, M; Ho, AD; Hoepfner, S; Luft, T; Weber-Nordt, R | 1 |
| Bermudez, M; Cañete, A; Castel, V; De la Rubia, J; Fernandez, J; Verdeguer, A | 1 |
| Fujisawa, Y; Hamaki, T; Heike, Y; Hori, A; Imataki, O; Kami, M; Kim, SW; Kishi, Y; Kojima, R; Makimoto, A; Masuo, S; Murashige, N; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
| Chen, Y; Han, W; Hong, H; Huang, X; Lu, D | 1 |
| BELDOTTI, L; SCHWARTZ, RS | 1 |
| Adkins, D; Blum, W; Brown, R; Chohan, R; Devine, S; DiPersio, JF; Goodnough, LT; Graubert, T; Khoury, H; Tomasson, M; Vij, R | 1 |
| Bahceci, E; Cooper, DL; Seropian, S | 1 |
| Aulagner, G; Bertrand, Y; Bleyzac, N; Galambrun, C; Jelliffe, RW; Maire, PH; Martin, P; Souillet, G | 1 |
| Butt, NM; Clark, RE; McGinnity, N | 1 |
| Liu, QF; Liu, XL; Meng, FY; Sun, J; Xu, B; Xu, D; Zhang, Y; Zhou, SY | 1 |
| Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF | 1 |
| Höffken, K; Issa, MC; Kasper, C; Mügge, LO; Sayer, HG; Schilling, K; Scholl, S | 1 |
| Alonzo, TA; Barnard, DR; Buxton, AB; Gold, S; Kalousek, D; Kobrinsky, N; Lange, BJ; Neudorf, S; Sanders, J; Wallace, JD; Woods, WG | 1 |
| Chan, G; Foss, FM; Gorgun, G; Grodman, H; Lawrence, D; Mahajan, A; Miller, KB; Relias, V; Roberts, TF; Schenkein, DP; Sprague, K | 1 |
| Atsuta, Y; Furukawa, T; Hamajima, N; Hirabayashi, N; Hirai, H; Hiraoka, A; Iseki, T; Iwato, K; Izutsu, K; Kanda, Y; Kasai, M; Kawa, K; Kodera, Y; Maruta, A; Mitsui, H; Okamoto, S; Sakamaki, H | 1 |
| Aschan, J; Larsson, K; Ljungman, P; Remberger, M; Ringdén, O; Winiarski, J | 1 |
| Bardy, P; Doherty, K; Grigg, A; Heatley, S; Hughes, T; Mullighan, C; Schwarer, A; Szabo, F; Szer, J; Tait, B; To, B | 1 |
| Fujioka, T; Ishida, Y; Numaoka, H; Omori, S; Ono, Y | 1 |
| Aker, M; Bloom, AI; Muszkat, M; Or, R; Resnick, IB; Sasson, T; Shapira, MY; Slavin, S; Verstandig, A; Zilberman, I | 1 |
| Alyea, E; Antin, JH; Cutler, C; Fisher, DC; Ho, V; Hochberg, E; Kim, HT; Lee, SJ; Levin, J; Miklos, D; Soiffer, RJ; Sonis, S | 1 |
| Hirokawa, M; Miura, I; Sawada, K | 1 |
| Ayash, L; Braun, T; Ratanatharathorn, V; Reynolds, C; Silver, S; Uberti, JP | 1 |
| Andresen, S; Bolwell, B; Kalaycio, M; Kuczkowski, E; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Cetkovic-Cvrlje, M; Uckun, FM | 1 |
| Angelov, G; Beloeil, L; Marvel, J; Michallet, MC; Quéméneur, L; Revillard, JP; Tomkowiak, M | 1 |
| Kallianpur, AR | 1 |
| Chen, H; Chen, YH; Dong, LJ; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Lu, J; Ren, HY; Wang, JB; Wu, T; Xu, LP | 1 |
| Choi, SJ; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Ryu, SG; Seol, M | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Rao, PS | 1 |
| Balon, J; Bieniaszewska, M; Bieniaszewski, L; Hałaburda, K; Hellmann, A; Pawłowski, R; Piekarska, A; Reichert, M | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Ashouri, A; Bahar, B; Eghbal, L; Ghavamzadeh, A; Gholibeikian, S; Iravani, M; Mousavi, A; Samiee, S | 1 |
| Alyea, E; Antin, JH; Cutler, C; Harrison, MJ; Ho, V; Hoffmeister, L; Kim, HT; Laglenne, P; Lee, SJ; Li, S; Soiffer, R; Sonis, S; Szeto, KC | 1 |
| Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Locatelli, F; Maarten Egeler, R; Montgomery, SM; Webb, D; Winiarski, J | 1 |
| Aisa, Y; Ikeda, Y; Ishida, A; Mori, T; Okamoto, S; Uemura, T; Yamada, Y | 1 |
| Chayama, K; Endo, C; Hamada, S; Hashii, Y; Inagaki, J; Inoue, M; Kawa, K; Kishimoto, T; Miyamura, T; Nakano, T; Nomura, K; Okamura, T; Park, YD; Saito, I; Sakata, N; Sasabe, M; Sato, E; Sawada, A; Yasui, M; Yumura-Yagi, K | 1 |
| Chen, H; Chen, Y; Han, W; Huang, XJ; Jiang, Q; Liu, D; Liu, K; Lu, D; Xu, L; Zhang, Y | 1 |
| Carpenter, P; Flowers, ME; Funke, VA; Giaccone, L; Hooper, H; Martin, P; Moravec, C; Storb, R | 1 |
| Deeg, HJ; Leisenring, W; Martin, PJ; Sorror, ML; Storb, R | 2 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Xu, LP; Zhang, YC | 1 |
| Brunet, S; Caballero, MD; Carreras, E; de León, A; del Cañizo, MC; Díez-Campelo, M; López-Fidalgo, J; Martino, R; Pérez-Simón, JA; San Miguel, JF; Sierra, J; Urbano, A; Valcárcel, D | 1 |
| Chauncey, TR; Deeg, HJ; Flowers, ME; Kahl, C; Leisenring, W; Martin, PJ; Sanders, JE; Storb, R | 1 |
| Benson, DM; Blum, W; Grady, T; Kennedy, MS; Krugh, D; Marcucci, G; O'Donnell, L; Williams, JD | 1 |
| Conte, ML; Indolfi, P; La Manna, A; Locatelli, F; Nobili, B; Perrotta, S; Rossi, F | 1 |
| Cetkovsky, P; Maalouf, J; Pohlreich, D; Vitek, A | 1 |
| Bélanger, R; Busque, L; Chamakhi, I; Dhédin, N; Ducruet, T; Fish, D; Perreault, C; Roy, DC; Roy, J; Sauvageau, G | 1 |
| Fujimori, Y; Hara, H; Itoi, H; Itsukuma, T; Kai, S; Misawa, M; Nakajima, T; Nishioka, K; Nomura, K; Ogawa, H; Okada, M; Takatsuka, H; Toda, A; Wakae, T | 1 |
| Martin, P; Potter, JD; Robien, K; Schubert, MM; Storb, R; Ulrich, CM; Yasui, Y | 1 |
| Bardy, P; Diviney, M; Grigg, A; Holdsworth, R; Hoyt, R; King, B; Macgregor, L; McCluskey, J; Murphy, N; Szer, J; Tait, BD | 1 |
| Bradstock, KF; Gottlieb, D; Grigg, A; Hertzberg, M; Hoyt, R; Huang, G; Roberts, A; Szer, J | 1 |
| Kupatawintu, P; O-Charoen, R; Seksarn, P; Vanichsetakul, P | 1 |
| Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
| Furst, DE; Georges, GE; Henstorf, G; Langston, AA; Lee, J; McSweeney, PA; Nash, RA; Nelson, JL; Shulman, H; Storb, R; Sullivan, KM; Wener, M | 1 |
| Jeffes, E; McCullough, JL; Weinstein, GD | 1 |
| Blanche, S; Casanova, JL; Cavazzana-Calvo, M; Fischer, A; Le Deist, F; Neven, B; Ouachée-Chardin, M; Picard, C; Renella, R | 1 |
| Cantu-Rodríguez, O; Gomez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, H; Herrera-Garza, J; Jaime-Pérez, J; Mancias-Guerra, C | 1 |
| Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
| Anderlini, P; Champlin, RE; Couriel, D; de Lima, M; Giralt, S; Hosing, C; Khouri, IF; Korbling, M; Lekakis, L; Martin, T; Shpall, EJ | 1 |
| Georges, GE; Mielcarek, M; Storb, R | 1 |
| Frei, E; Freund, M; Hartung, G; Hofmeister, N; Junghanss, C; Kleine, HD; Schrenk, HH; Sievert, K; Steiner, B; Terpe, H; Wolff, D | 1 |
| Jiang, XF; Sheng, BJ | 1 |
| Bensinger, W | 1 |
| Blaise, D; de Lavallade, H; El-Cheikh, J; Faucher, C; Fürst, S; Mohty, M | 1 |
| Formánková, R; Hubácek, P; Keslová, P; Król, L; Kulich, M; Sedlácek, P; Srámková, L; Starý, J | 1 |
| Hamaguchi, M; Iida, H; Kohno, A; Matsuo, K; Miyamura, K; Morishita, Y; Murata, M; Narimatsu, H; Oba, T; Sawa, M; Terakura, S; Uchida, T; Watanabe, M | 1 |
| Alyea, E; Antin, JH; Cutler, C; Ho, VT; Koreth, J; Li, S; Soiffer, RJ | 1 |
| Arce, JA; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Kennedy-Nasser, AA; Khan, SP; Krance, RA; Leung, KS; Mahajan, A; Weiss, HL | 1 |
| Mehta, J; Singhal, S | 2 |
| Inamoto, Y; Kodera, Y; Kuwatsuka, Y; Miyamura, K; Oba, T; Sugimoto, K; Takahashi, T; Terakura, S; Tsujimura, A; Yasuda, T | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP | 1 |
| Altmaier, EM; Carter, S; Davies, SM; Henslee-Downey, J; Hochhausen, N; McQuellon, R; Papadopolous, E | 1 |
| Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS | 1 |
| Holler, E | 1 |
| Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
| Kinoshita, T; Murata, M; Naoe, T; Narimatsu, H; Sugimoto, K; Terakura, S | 1 |
| Adachi, N; Fujita, N; Goto, H; Hasegawa, D; Hirota, Y; Inukai, T; Ishida, H; Kanegane, H; Kato, K; Kigasawa, H; Kikuchi, A; Kikuta, A; Kishimoto, T; Kobayashi, M; Koike, K; Kuroda, H; Matsuzaki, A; Nagatoshi, Y; Nakamura, K; Nakano, T; Nakazawa, Y; Okada, K; Osugi, Y; Tanaka, R; Tokuda, K; Tsuchida, M; Uoshima, N; Watanabe, A; Yabe, H; Yagasaki, H; Yoshihara, T | 1 |
| Gawlicka, G; Giebel, S; Holowiecki, J; Markiewicz, M; Miszczyk, L; Tomaszewska, R; Wojnar, J; Wyleioł, I | 1 |
| Collins, RH; Karandikar, NJ; Mundy, DI; Ortega, SB; Sathe, A | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Aisa, Y; Ikeda, Y; Mihara, A; Mori, T; Nakazato, T; Okamoto, S; Shimizu, T; Yamane, A; Yamazaki, R | 1 |
| Bahlis, NJ; Balogh, A; Brown, CB; Chaudhry, MA; Geddes, M; Larratt, L; Quinlan, D; Russell, JA; Savoie, ML; Stewart, DA; Storek, J; Turner, AR | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Remberger, M; Ringdén, O | 1 |
| Abe, T; Aizawa, Y; Furukawa, T; Izumi, N; Kurasaki, T; Masuko, M; Okazuka, K; Sato, N; Takahashi, M; Toba, K; Tsukada, N; Yano, T | 1 |
| Alvarez, I; Arranz, R; Caballero, D; Canales, M; Cavet, J; Garcia-Conde, J; Goldstone, AH; Hunter, A; Linch, DC; Mackinnon, S; Mahendra, P; Milligan, D; Parker, A; Peggs, KS; Qian, W; Ribera, JM; Sanz, G; Sierra, J; Sureda, A; Thomson, K; Urbano-Ispizua, A | 1 |
| Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T | 1 |
| Fujioka, T; Hasei, H; Iiboshi, Y; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Ogawa, H; Soma, T; Tamaki, H; Taniguchi, Y; Tazuke, Y; Yoshihara, S | 1 |
| Carter, SL; Freifeld, AG; Godder, KT; High, KP; Kernan, NA; Mendizabal, AM; Papanicolaou, GA; van Burik, JA; Wagner, JE; Yanovich, S | 1 |
| Hatano, M; Inagaki, J; Isomura, N; Nagatoshi, Y; Okamura, J; Sakiyama, M | 1 |
| Choi, G; Hong, W; Kim, YC; Shin, J; Song, H | 1 |
| Das, P; Diezi, M; Doyle, J; Dupuis, LL; Price, V; Punnett, A; Sung, L | 1 |
| Curtis, DJ; Grigg, AP; Hoyt, R; Macgregor, L; Ritchie, DS; Roberts, AW; Szer, J | 1 |
| Aghdaie, MH; Azarpira, N; Daraie, M; Geramizadeh, B; Ramzi, M | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Alimoghaddam, K; Ashouri, A; Ghaffari, H; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Mahdavi, N; Mousavi, SA; Namdar, R; Nedaeifard, L; Shamshiri, A | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Shi, HX; Wang, Y; Xu, LP | 1 |
| Inamoto, Y; Kodera, Y; Kuwatsuka, Y; Miyamura, K; Murata, M; Naoe, T; Oba, T; Onizuka, M; Sugimoto, K; Terakura, S | 1 |
| Gupta, V; Kamel-Reid, S; Kuruvilla, J; Lipton, JH; Messner, H; Minden, M; Siegal, D; Sutherland, R; Xu, W | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Doney, K; Flowers, ME; Furlong, T; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, R | 1 |
| Ayuk, F; Bacher, U; Binder, T; Diyachenko, G; Eiermann, T; Erttmann, R; Fehse, B; Kabisch, H; Kröger, N; Panse, J; Wolschke, C; Zabelina, T; Zander, AR | 1 |
| Gahrton, G; Lönnqvist, B; Lundgren, G; Ringdén, O; Wahren, B | 1 |
| Helbig, W; Kubel, M; Schultze, W; Schwenke, H | 1 |
| Deeg, HJ; Hansen, JA; Lum, LG; Ochs, HD; Storb, R; Thomas, ED; Witherspoon, RP | 1 |
| Parkman, R; Sullivan, KM | 1 |
| Avanzi, G; Bacigalupo, A; Frassoni, F; Marmont, AM; Podesta', M; van Lint, MT; Veneziano, G; Vitale, V | 1 |
| Gastineau, DA; Hoagland, HC; Moore, SB; Wick, MR | 1 |
| Bacigalupo, A; Frassoni, F; Marziano, G; Ricci, G; Scielzo, G; Siracusa, G; Tomassini, A; Van Lint, MT; Vitale, V; Vitali, ML | 1 |
| Bellingham, AJ; Bunch, C; Summerfield, GP; Woodrow, JC | 1 |
| Appelbaum, FR; Deeg, HJ; Graham, TC; Kennedy, MS; Storb, R; Thomas, ED | 1 |
| Jansen, J; Zwaan, FE | 1 |
| Boileau, J; Bonny, Y; Cousineau, S; D'Angelo, G; Gyger, M; Lacombe, M; Lavallee, R; Perreault, C; Tawil, E | 1 |
| Calvo, W; Carbonell, F; Fliedner, TM; Gerhartz, H; Körbling, M; Kratt, E; Nothdurft, W; Ross, WM | 1 |
| Deeg, HJ; Storb, R | 2 |
| Cheung, NK; Coccia, PF; Gordon, E; Graham-Pole, J; Gross, S; Herzig, RH; Lazarus, HM; Spitzer, TR; Strandjord, S; Warkentin, PI | 1 |
| Filipovich, A; Kersey, J; Neudorf, S; Ramsay, N | 1 |
| Ekblom, M; Häyry, P; Leskinen, R; Renkonen, R; Ruutu, T; Volin, L | 1 |
| Aker, SN; Cheney, CL; Deeg, HJ; Lenssen, P; Moe, GL | 1 |
| Kalliomäki, JL; Korvenranta, H; Meurman, L; Nikoskelainen, J; Rajamäki, A; Söderström, KO; Toivanen, A | 1 |
| Deeg, HJ; Storb, R; Thomas, ED | 1 |
| Devergie, A; Dokhelar, MC; Gluckman, E; Lipinski, M; Tetaud, C; Tursz, T; Wiels, J | 1 |
| Doney, KC; Storb, R; Thomas, ED; Weiden, PL | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Grigg, AP; Lickliter, JD; Roberts, AW | 1 |
| Anasetti, C; Aro, RM; Collins, RH; Devine, SM; Fay, JW; Nash, RA; Piñeiro, LA; Przepiorka, D; Storb, RF; Wingard, JR | 1 |
| Anasetti, C; Appelbaum, FR; Doney, K; Etzioni, R; Furlong, T; Gooley, T; Martin, P; Nash, RA; Slattery, J; Storb, R | 1 |
| Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Baruchel, A; Devergie, A; Esperou Bourdeau, H; Hirsch, I; Moussalem, M; Parquet, N; Ribaud, P; Schaison, G; Socie, G; Traineau, R | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Hampl, W; Heimpel, H; Hertenstein, B; Koszinowski, U; Mertens, T; Wiesneth, M | 1 |
| Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
| Carreras, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Dagis, AC; Molina, A; Nademanee, A; O'Donnell, M; Parker, P; Schmidt, GM; Smith, EP; Snyder, DS; Stein, A; Stepan, DE | 1 |
| Braude, I; Deeg, HJ; Graham, TC; Huss, R; Schuening, FG; Storb, R; Yu, C | 1 |
| Betker, R; Hoffknecht, M; Horstmann, M; Kabisch, H; Krüger, W; Stockschläder, M; Zander, A | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
| Ash, RC; Auerbach, AD; Bortin, MM; Butturini, A; Camitta, BM; Champlin, RE; Friedrich, W; Gale, RP; Gluckman, E; Good, RA; Gordon-Smith, EC; Harris, RE; Horowitz, MM; Klein, JP; Ortega, JJ; Pasquini, R; Ramsay, NK; Sobocinski, KA; Speck, B; Vowels, MR; Zhang, MJ | 1 |
| De Witte, T; Dompeling, EC; Schattenberg, A; Swaak, AJ; Vreugdenhil, G | 1 |
| Appelbaum, FR; Deeg, HJ; Fitzsimmons, W; Graham, TC; Pepe, M; Pettinger, M; Raff, RF; Sale, G; Storb, R; van der Jagt, R | 1 |
| Appelbaum, FR; Bensinger, W; Clift, RA; Deeg, HJ; Doney, K; Hansen, JA; Martin, PO; Sanders, J; Storb, R; Weaver, CH | 1 |
| Blaise, D; Leblond, V; Maraninchi, D; Marit, G; Michallet, M; Olive, D | 1 |
| Bolme, P; Nilsson, C; Smedler, AC | 1 |
| Bellazzi, R; Quaglini, S | 1 |
| Chen, YC; Lin, DT; Lin, KH; Lin, KS; Lui, LT; Wang, CH | 1 |
| Chan, TK; Chiu, EK; Yuen, P | 1 |
| Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
| Aschan, J; Lönnqvist, B; Lungman, P; Markling, L; Remberger, M; Ringdén, O | 1 |
| Andström, E; Aschan, J; Ljungman, P; Lönnqvist, B; Remberger, M; Ringdén, O | 1 |
| Jones, AR; Poon, MC; Ruether, BA; Russell, JA; Woodman, RC | 1 |
| Catovsky, D; Horton, C; Mehta, J; Milan, S; Powles, R; Tait, D; Treleaven, J | 1 |
| Boström, L; Hägglund, H; Nilsson, B; Remberger, M; Ringdén, O | 1 |
| Andström, E; Aschan, J; Ljungman, P; Remberger, M; Ringdén, O | 1 |
| Aschan, J; Ljungman, P; Lönnqvist, B; Markling, L; Remberger, M; Ringden, O | 1 |
| Hale, G; Waldmann, H | 1 |
| Aschan, J; Ringdén, O | 1 |
| Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
| Chandanayingyong, D; Issaragrisil, S; Piankijagum, A; Suvatte, V; Visuthisakchai, S | 1 |
| Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
| Berkman, E; Comenzo, R; Erban, JK; Fogaren, T; Hirsch, CA; Miller, KB; Rabson, A; Schenkein, DP | 1 |
| Abe, A; Kato, H; Matsuoka, A; Matsushita, T; Tahara, T; Takeo, T; Towatari, M; Toyozumi, H; Yamamoto, K; Yamazaki, T | 1 |
| Cooley, MA; Donnellan, M; Farrell, C; Fussell, ST | 1 |
| Anasetti, C; Appelbaum, F; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Hansen, J; Leisenring, W; Storb, R | 1 |
| Fitzsimmons, WE; Ghalie, R; Kaizer, H; Manson, S; Weinstein, A | 1 |
| Fujita, H; Hashimoto, Y; Hataoka, K; Kanamori, H; Maeda, K; Ohtsuka, M; Okamoto, R; Tamura, T; Tanabe, J; Yamazaki, E | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M | 1 |
| Crawford, SW; Longton, G; Storb, R | 1 |
| Collis, CH; Gale, RF; Gandhi, L; Hamon, MD; Macdonald, ID; Prentice, HG; Skeggs, DB; Smith, OP | 1 |
| Bloom, EJ; Schwinghammer, TL | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP | 1 |
| Blazar, B; Filipovich, A; Kersey, J; McGlave, P; Miller, W; Ramsay, N; Weisdorf, D | 1 |
| Anasetti, C; Deeg, HJ; Doney, K; Hansen, J; Sanders, JE; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Aschan, J; Klaesson, S; Ljungman, P; Lönnqvist, B; Ringdén, O; Sundberg, B | 1 |
| Brown, SA; Cave, ML; Cibull, ML; Eichhorn, TR; Henslee-Downey, PJ; Jennings, CD; Jezek, DA; Rhoades, JL; Sinn, HP; Thompson, JS | 1 |
| Buckley, JD; Feig, SA; Hammond, GD; Kim, T; Lampkin, B; Nesbit, ME; Versteeg, CM; Woods, WG | 1 |
| Filippi, C; Garbe, L; Garnier, G; Gratecos, N; Michiels, JF; Pesce, A; Poitou, G; Rosenthal, E; Taillan, B; Vinti, H | 1 |
| Appelbaum, FR; Bakke, L; Bensinger, WI; Bianco, JA; Bowden, RA; Buckner, CD; Clift, RA; McDonald, GB; Schubert, M; Singer, JW | 1 |
| Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
| Ford, D; Lam-Po-Tang, R; Shing, MM; Trickett, AE; Vowels, MR | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P | 1 |
| Anasetti, C; Choo, SY; Hansen, JA; Longton, GM; Martin, PJ; Mickelson, EM; Petersdorf, EW; Smith, AG | 1 |
| Ringdén, O | 2 |
| Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
| Alessandrino, EP; Aversa, F; Calori, E; Dini, G; Garbarino, L; Lamparelli, T; Lanino, E; Locatelli, F; Marenco, P; Medugno, D | 1 |
| Grigg, A | 1 |
| Hunter, A; Rogers, S; Russell, N | 1 |
| Anderson, JR; Armitage, JO; Bierman, P; Bishop, MR; Cowles, MK; Kessinger, A; Martin-Algarra, S; Reed, E; Tarantolo, S; Vose, JM | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| Arseniev, L; Diedrich, H; Link, H | 1 |
| Issaragrisil, S; Piankijakum, A; Suvatte, V; Tang-naitrisorana, Y; Visuthisakchai, S | 1 |
| Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
| Conter, V; D'Angelo, P; Dampier, C; Jankovic, M; Johnson, FL; Masera, G; Rizzari, C | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Noto, S; Sakurada, K; Tanaka, J | 1 |
| Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Deeg, HJ; Fitzsimmons, WE; Graham, TC; Huss, R; Scheuning, FG; Seidel, K; Storb, R; Yu, C | 1 |
| Atkinson, K; Downs, K | 1 |
| Falk, PM; Kagan, AR; Kogut, N; Morgan, TL; Shah, KH; Tome, M | 1 |
| Alegre, A; Benet, I; Besalduch, J; Brunet, S; Carreras, E; de la Rubia, J; Díaz, MA; Domingo-Albós, A; García-Conde, J; Hernández, F; Moraleda, JM; Ojeda, E; Petit, J; Rozman, C; Sanz, G; Solano, C; Urbano-Ispizua, A; Vivancos, P | 1 |
| Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
| Anasetti, C; Deeg, HJ; Fay, JW; Fitzsimmons, WE; Furlong, T; Gooley, T; Hansen, JA; Maher, RM; Martin, P; McSweeney, PA; Nash, RA; Piñeiro, LA; Storb, R; Sullivan, KM | 1 |
| Bacigalupo, A; Fiere, D; Frassoni, F; Gluckman, E; Gorin, NC; Harrousseau, JL; Jouet, JP; Labopin, M; Reiffers, J; Ringdén, O; Vernant, JP | 1 |
| Appelbaum, FR; Bensinger, WI; Benyunes, M; Buckner, CD; Clift, R; Demirer, T; Lee, M; Martin, P; Rowley, S; Schiller, G; Shannon-Dorcy, K; Storb, R | 1 |
| Andersson, B; Besien, K; Champlin, R; Cleary, K; Deisseroth, AB; Fischer, H; Fitzsimmons, W; Fritsche, H; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Le Bherz, D; Maher, R; Mehra, R; Przepiorka, D; Woo, M | 1 |
| Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
| Apperley, JF; Gratwohl, A; Niederwieser, D; Ruutu, T | 1 |
| Baker, KS; DeLaat, CA; Filipovich, AH; Gross, TG; Harris, R; Loechelt, B; Shapiro, RS; Steinbuch, M | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| Adams, PT; Jacobson, P; Ratanatharathorn, V; Scalzo, A; Silver, SM; Uberti, JP | 1 |
| De'Arce, M; Gardiner, N; Lawler, M; McCann, SR; O'Riordan, J | 1 |
| Connaghan, DG; Devine, SM; Dix, SP; Fitzsimmons, WE; Geller, RB; Heffner, LT; Hillyer, CD; Holland, HK; Keller, J; Lin, LB; Maher, RM; Maurer, D; O'Toole, K; Rodey, GE; Wingard, JR; Winton, EF | 1 |
| Bekersky, I; Boswell, G; Devine, SM; Fay, JW; Fitzsimmons, W; Klein, JL; Maher, RM; Nash, RA; Przepiorka, D; Ratanatharathorn, V; Wingard, JR | 1 |
| Hovi, L; Parto, K; Saarinen-Pihkala, UM; Vettenranta, K | 1 |
| Fitzsimmons, WE; Sale, G; Seidel, K; Storb, R; Yu, C | 1 |
| Grigg, A; Harun, MH; Szer, J | 1 |
| Erttmann, R; Hassan, HT; Krog, C; Krüger, W; Stockschläder, M; Zander, AR; Zeller, W | 1 |
| Cerezo, L; Domínguez, P; López, M; Marín, A; Martín De Vidales, C; Pérez Torrubia, A; Zapatero, A | 1 |
| Mihara, M; Moriya, Y; Takagi, N; Takeda, Y; Urakawa, K | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Chauncey, T; Clift, R; Deeg, HJ; Doney, K; Flowers, ME; Hansen, JA; Leisenring, W; Martin, P; Pepe, M; Pettinger, M; Sanders, J; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
| Akan, H; Arslan, O; Beksaç, M; Dilek, I; Gürman, G; Ilhan, O; Koç, H; Konuk, N; Ozcan, M; Uysal, A | 1 |
| Antin, JH; Ballen, KK; Bierer, BE; Ferrara, JL; Gilliland, DG; Guinan, EC; Hsieh, CC; Parsons, SK; Rimm, IJ; Weinstein, HJ | 1 |
| Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S | 1 |
| Amill, B; Berlanga, JJ; Boqué, C; Brunet, S; Canals, C; Cancelas, JA; Domingo-Albós, A; Ferra, C; Gallardo, D; García-López, J; Grañena, A; Martín-Henao, G; Martínez, C; Martino, R; Picón, M; Sureda, A; Torrico, C | 1 |
| Gooley, T; Hackman, RC; Ko, CW; Lee, SP; McDonald, GB; Myerson, D; Sale, GE; Schoch, HG; Shulman, HM | 1 |
| Bunin, N; Darbyshire, PJ; Davies, SC; Dinndorf, P; Kurtzberg, J; Leisenring, W; Mentzer, WC; Patience, M; Roberts, IA; Rogers, ZR; Scott, JP; Smith, FO; Sullivan, KM; Wall, DA; Walters, MC; Wayne, AS; Wiley, J; Yeager, A | 1 |
| Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Bandini, G; Bonini, A; Campanini, E; Mangianti, S; Motta, MR; Remiddi, C; Rizzi, S; Rondelli, D; Rosti, G; Testoni, N; Tura, S; Zuffa, E | 1 |
| Flowers, ME; Longton, G; Schubert, M; Storb, R; Sullivan, KM; Wagner, JL | 1 |
| Beksac, M; Bernaudin, F; Brichard, B; Gluckman, E; Locatelli, F; Miniero, R; Nagler, A; Roberts, I; Rocha, V; Saracco, P; Yaniv, I | 1 |
| Landaw, EM; Paquette, RL; Tran, L | 1 |
| Boccadoro, M; Caracciolo, D; Cavallaro, AM; Corradini, P; Indovina, A; Majolino, I; Marcenò, R; Palumbo, A; Pileri, A; Santoro, A; Scimè, R; Tarella, C | 1 |
| Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
| Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
| Anasetti, C; Leisenring, W; Sanders, J; Sandmaier, BM; Storb, R; Stucki, A | 1 |
| Aschan, J; Carlens, S; Hägglund, H; Klaesson, S; Ljungman, P; Lönnqvist, B; Mattsson, J; Remberger, M; Ringdén, O; Svahn, BM; Winiarski, J | 1 |
| Barrett, AJ; Bunjes, D; Hale, G; Horowitz, MM; Prentice, HG; Spence, D; Waldmann, H; Zhang, MJ | 1 |
| Dieckman, K; Fischer, G; Greinix, HT; Kalhs, P; Keil, F; Lechner, K; Leitner, G; Malzer, R; Rabitsch, W; Reiter, E | 1 |
| Cukrová, V; Dolezalová, L; Gasová, Z; Hrabánek, J; Hrubá, A; Kobylka, P; Korínková, P; Loudová, M; Marinov, J; Sajdová, J; Sieglová, Z; Vítek, A | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Alvarez, MA; Falcon, M; García-Castellano, JM; Gomez, P; Herrera, C; Martin, C; Martinez, F; Roman, J; Serrano, J; Torres, A | 1 |
| Glomstein, A; Gustafsson, G; Jonmundsson, G; Mellander, L; Nysom, K; Ringdén, O; Saarinen-Pihkala, UM; Schroeder, H | 1 |
| Bielack, S; de Wit, M; Dürken, M; Erttmann, R; Jaburg, N; Kabisch, H; Kröger, N; Krüger, W; Löliger, C; Renges, H; Rüssmann, B; Stockschläder, M; Wacker-Backhaus, G; Zabelina, T; Zander, AR | 1 |
| Basara, N; Basu, O; Beelen, DW; Blau, IW; Bornhäuser, M; Ehninger, G; Fauser, AA; Hägglund, H; Hölig, K; Remberger, M; Ringdén, O; Runde, V | 1 |
| Chan, KW; Danielson, M; Mattewada, V; Mullen, CA; Petropoulos, D; Przepiorka, D | 1 |
| Burge, S; Sheerin, S; Stone, N | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Ichinohe, T; Kitahara, M; Otsu, S; Shimada, H; Shiomura, T; Yago, K | 1 |
| Bergna, MI; Cánepa, C; Gardenal, L; Gil, MA; Italiano, C; Klein, G; Malacalza, J; Mansilla, E; Marin, GH; Mendez, MC; Menna, ME; Orlando, S; Perez, M; Piccinelli, G; Saba, S | 1 |
| Gooley, T; Hansen, JA; Lin, MT; Martin, EG; Martin, PJ; Pei, J; Petersdorf, EW; Smith, AG; Tseng, LH | 1 |
| Anderlini, P; Andersson, BS; Braunschweig, I; Champlin, R; Chan, KW; Claxton, D; Cleary, K; Donato, M; Fischer, H; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Körbling, M; Mehra, R; Przepiorka, D; Ueno, NT; van Besien, K | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Bacigalupo, A; Benvenuto, F; Berisso, G; Bregante, S; Figari, O; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT | 1 |
| Kasai, M; Kato, C; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Ueda, R; Yamanishi, H | 1 |
| Deeg, HJ; Linsley, P; Nash, RA; Sale, G; Seidel, K; Storb, R; Yu, C | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Schmetzer, B | 1 |
| Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
| Anderlini, P; Andersson, BS; Braunschweig, I; Champlin, R; Claxton, D; Cleary, K; Donato, M; Fischer, H; Folloder, J; Fritsche, H; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, IF; Mehra, R; Przepiorka, D; Saliba, R; Tonai, R; Ueno, NT; van Besien, K | 1 |
| Albrechtsen, D; Brinch, L; Egeland, T; Evensen, SA; Heldal, D; Solheim, BG; Steen, R; Tjønnfjord, G | 1 |
| Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM | 1 |
| Hamazaki, T; Inoue, A; Inoue, M; Kawa, K; Kishimoto, T; Okamura, T; Sakata, N; Sasabe, M; Yagi, K; Yasui, M | 1 |
| Dunn, R; Ferrara, J; Hutchinson, RJ; Levine, JE; Ratanatharathorn, V; Yanik, G | 1 |
| Arcese, W; Bacigalupo, A; Bruno, B; Dallorso, S; Di Bartolomeo, P; Fagioli, F; Lawler, M; Locasciulli, A; Locatelli, F; McCann, S; Van-Lint, MT; Zecca, M | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Hahn, J; Holler, E; Kunzmann, R; Reisser, S; Veelken, H; Wäsch, R | 1 |
| Anasetti, C; Antin, JH; Avalos, BR; Bartels, P; Buell, D; Davies, S; Fay, JW; Fitzsimmons, W; Karanes, C; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; Yeager, AM | 1 |
| Bekasi, A; Cornish, J; Gadner, H; Klingebiel, T; Locatelli, F; Minkov, M; Niethammer, D; Ortega, J; Peters, C; Souillet, G; Stary, J; Vossen, J | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
| Appelbaum, FR; Davis, C; Gooley, T; Nash, RA | 1 |
| Bartlett-Pandite, L; Kharfan Dabaja, MA; Markoe, AM; Morgensztern, D | 1 |
| Boeckh, M; Seidel, K; Storb, R; Wagner, JL | 1 |
| Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
| Ilan, Y; Menachem, Y; Nagler, A | 1 |
| Blume, KG; Chauncey, T; Feinstein, L; Flowers, C; Georges, G; Kiem, HP; Little, MT; Maloney, D; Maris, M; McSweeney, PA; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, B; Shizuru, J; Storb, R; Woolfrey, A; Zaucha, JM | 1 |
| Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
| Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
| Cetkovic-Cvrlje, M; Liu, XP; Roers, BA; Uckun, FM; Waurzyniak, B | 1 |
| Bylsma, GW; Hall, AJ; Szer, J; West, R | 1 |
| Chen, MG; Gastineau, DA; Gertz, MA; Harmsen, WS; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A | 1 |
| Domingues-Martins, M; França, CM; Pallotta Filho, RS; Soares de Araújo, N; Volpe, A | 1 |
| Simpson, D | 1 |
| Hamajima, N; Matsuo, K; Morishima, Y; Suzuki, R | 1 |
| Alessandrino, PE; Bacigalupo, A; Barbanti, M; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; Van Lint, MT | 1 |
| Kabisch, H; Kröger, N; Krüger, W; Renges, H; Schetelig, J; Schrum, J; Siegert, W; Stute, N; Zabelina, T; Zander, AR | 1 |
| Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
| Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
| Anderlini, P; Cabanillas, FF; Champlin, RE; Donato, ML; Gajewski, JL; Giralt, SA; Hagemeister, FB; Ippoliti, C; Khouri, IF; Korbling, M; Lee, MS; McLaughlin, P; Okoroji, GJ; Saliba, RM; Younes, A | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
| Arranz, R; Brunet, S; Bueno, J; Cabrera, R; Carreras, E; Conde, E; Conde, JG; Fernández-Rañada, JM; Iriondo, A; Maldonado, J; Marín, P; Odriozola, J; Pajuelo, FJ; Petit, J; Rodriguez-Salvanés, F; Sanz, MA | 1 |
| Huang, H; Huang, J; Jin, J; Lin, M; Luo, Y; Meng, H; Qian, W | 1 |
| Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
| Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A | 1 |
| Aschan, J; Barkholt, L; Hentschke, P; Ljungman, P; Mattsson, J; Remberger, M; Ringdén, O | 1 |
| Chen, H; Ji, S; Wang, H | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Eibl, M; Greinix, HT; Gritsch, B; Hinterberger, W; Kalhs, P; Knöbl, P; Krieger, O; Lechner, K; Linkesch, W; Lutz, D; Nachbaur, D; Niederwieser, D; Rosenmayr, A | 1 |
| Buckner, CD; Clift, RA; Fefer, A; Goodell, BW; Johnson, FL; Neiman, PE; Sanders, JE; Singer, J; Storb, R; Thomas, ED; Weiden, PL | 1 |
| Kersey, JH; Neely, AN; Neely, JE | 1 |
| Dicke, KA; Hendriks, W; Peters, L; Spitzer, G; Stevens, EE | 1 |
| Boström, L; Forsgren, M; Ringdén, O | 1 |
| Kersey, JH; Ringdén, O | 1 |
| Masaoka, T | 2 |
| Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R | 1 |
| Anasetti, C; Appelbaum, FR; Bowden, RA; Deeg, HJ; Doney, K; Longton, G; Nash, RA; Pepe, MS; Pettinger, M; Storb, R | 1 |
| Beelen, DW; Brandt, H; Graeven, U; Haralambie, E; Linzenmeier, G; Mahmoud, HK; Müller, KD; Quabeck, K; Sayer, HG; Schaefer, UW | 1 |
| Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
| Appelbaum, FR; Deeg, HJ; Fidler, JM; Graham, T; Pepe, M; Raff, RF; Sale, G; Schuening, F; Shulman, H; Storb, R | 1 |
| Blaise, D; Bordigoni, P; Esperou-Bourdeau, H; Gluckman, E; Kuentz, M; Michel, G; Milpied, N; Rubie, H; Thuret, I; Vernant, JP | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Dahllöf, G; Heimdahl, A; Lönnquist, B; Mattsson, T; Ringdén, O | 2 |
| Anasetti, C; Appelbaum, F; Doney, K; Longton, G; Martin, P; McDonald, G; Pepe, M; Stockschlaeder, M; Storb, R; Sullivan, K | 1 |
| Brown, R; Stevens, M; Tiedemann, K; Vowels, M | 1 |
| Klaesson, S; Ljungman, P; Lönnqvist, B; Persson, U; Ringdén, O; Sundberg, B | 1 |
| Appelbaum, F; Bianco, J; Buckner, CD; Clift, R; Petersen, F | 1 |
| Goldman, JM | 1 |
| Essell, JH; Halvorson, RD; Harman, GS; Johnson, RA; Rubinsak, JR; Snyder, MJ; Thompson, JM | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Martin, P; Pepe, M; Sanders, JE; Singer, J; Stewart, P; Storb, R; Sullivan, KM | 1 |
| Bogdanić, V; Grgić-Markulin, L; Jakić-Razumović, J; Kalenić, S; Labar, B; Mrsić, M; Nemet, D; Presecki, V; Vrtar, M; Vujasinović, S | 1 |
| Barnett, MJ; Deeg, HJ; Klingemann, HG; Nevill, TJ; Phillips, GL; Reece, DE; Shepherd, JD; Tirgan, MH | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R | 1 |
| Bacigalupo, A; Biggs, JC; Camitta, BM; Champlin, RE; Gale, RP; Gluckman, E; Gordon-Smith, EC; Horowitz, MM; Hows, JM; Marmont, AM | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M | 1 |
| Speck, B | 1 |
| Erdkönig, R; Klima, G; Köröszi, G; Margreiter, R; Oberhuber, G; Ofner, D; Schmid, T; Thaler, W | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
| Hervé, P | 1 |
| Anasetti, C; Appelbaum, FR; Buckner, CD; Deeg, HJ; Doney, K; Hansen, J; Martin, P; Pepe, M; Sanders, JE; Storb, R | 1 |
| Anasetti, C; Appelbaum, FR; Beatty, P; Bensinger, W; Buckner, CD; Doney, K; Fefer, A; Fisher, LD; Singer, J; Storb, R | 1 |
| Bacigalupo, A; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Scarpati, D; Sessarego, M; Van Lint, MT; Vitale, V | 1 |
| Attal, M; Bellanger, C; Blaise, D; Guyotat, D; Ifrah, N; Michallet, M; Olive, D; Reiffers, J; Vernant, JP; Vilmer, E | 1 |
| Appelbaum, FR; Buckner, CD; Clift, RA; Hansen, JA; Petersen, FB; Sanders, JE; Storb, R; Thomas, ED | 1 |
| Appelbaum, FR; Bianco, J; Buckner, CD; Epstein, C; Hansen, J; Higano, CS; Lipani, J; Mori, M; Nemunaitis, J; Storb, R | 1 |
| Bosson, JL; Chabannon, C; Corront, B; Gaspard, MH; Maraninchi, D; Michallet, M; Molina, L; Peissel, B; Reiffers, J; Stoppa, AM | 1 |
| Bourdeau-Esperou, H; Cosset, JM; Devergie, A; Gluckman, E; Socie, G; Traineau, R | 1 |
| Abe, F; Fujii, A; Fujii, H; Hayashi, M; Ito, J; Mae, T; Nemoto, K; Sugawara, Y; Takeuchi, T | 1 |
| Conard, P; Gaynon, P; Johnson, FL; Kowal-Vern, A; Nachman, J; Radhakrishnan, J; Trujillo, Y | 1 |
| Fleischhauer, D; Gassmann, W; Loeffler, H; Mueller-Ruchholtz, W; Uharek, L; Wottge, HU | 1 |
| Aschan, J; Gahrton, G; Ljungman, P; Ringdén, O; Sundberg, B; Winiarski, J | 1 |
| Parkman, R | 1 |
| Cahill, R; Cottler-Fox, M; Deeg, HJ; Pickle, LW; Spitzer, TR | 1 |
| Aschan, J; Båryd, I; Janossy, G; Ljungman, P; Lönnqvist, B; Markling, L; Pihlstedt, P; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
| Ladiges, WC; Storb, R; Thomas, ED | 1 |
| Anasetti, C; Appelbaum, FR; Beatty, P; Doney, K; Martin, P; Pepe, M; Stewart, P; Storb, R; Sullivan, KM; Witherspoon, R | 1 |
| Anasetti, C; Appelbaum, FR; Beatty, PG; Byers, V; Doney, K; Fisher, L; Martin, PJ; McDonald, GB; Sanders, JE; Schoch, G | 1 |
| Bogdanić, V; Dobrić, I; Francetić, I; Kastelan, A; Labar, B; Marusić, M; Mrsić, M; Nemet, D; Pavletić, Z; Plavsić, F | 1 |
| Anasetti, C; Appelbaum, FR; Bearman, SI; Beatty, P; Bensinger, WI; Buckner, CD; Clift, RA; Doney, K; Fisher, LD; Petersen, FB | 1 |
| Burnison, M; Champlin, RE; Gajewski, JG; Ho, WG; Holley, G; Nimer, SD; Petz, L; Selch, M; Winston, DJ; Yam, P | 1 |
| Ash, R; Beatty, P; Hows, JM; McGlave, PB | 1 |
| Dunphy, FR; Jagannath, S; LeMaistre, CF; Luke, DR; Meneghetti, CM; Spinolo, JA; Spitzer, G; Williams, LA; Yau, JC; Zagars, GK | 1 |
| Anasetti, C; Beatty, PG; Hansen, JA; Martin, PJ; Sanders, JE; Storb, R; Thomas, ED | 1 |
| Hermans, J; Zwaan, FE | 1 |
| Beelen, DW; Graeven, U; Grosse-Wilde, H; Kaiser, B; Quabeck, K; Sayer, HG; Schaefer, UW; Scheulen, ME; Wiefelspütz, J | 1 |
| Cockerill, FR; Rosenow, EC; Wilson, WR | 1 |
| Kanamaru, A; Kato, S; Kodera, Y; Masaoka, T; Moriyama, Y; Nakamura, H; Shibata, H; Shimosaka, A; Takaku, F | 1 |
| Andres, P; Fornes, G; Garcia-Castellano, JM; Gomez, P; Gomez-Villagran, JL; Herrera, C; Martinez, F; Rojas, R; Torres, A; Velasco, F | 1 |
| Appelbaum, FR; Banaji, M; Buckner, CD; Fefer, A; Fisher, L; Hansen, J; Storb, R; Sullivan, KM; Weiden, PL; Witherspoon, RP | 1 |
| Anasetti, C; Beatty, PG; Buckner, CD; Hansen, JA; Sanders, J; Storb, R; Thomas, ED | 1 |
| Bäckman, L; Janossy, G; Lönnqvist, B; Markling, L; Philstedt, P; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
| Szer, J | 1 |
| Bortin, MM; Dicke, KA; Gale, RP; Horowitz, MM; Masaoka, T; Ramsay, NK; Rimm, AA; Rozman, C; van Bekkum, DW; Weiner, RS | 1 |
| Anasetti, C; Appelbaum, F; Beatty, P; Bensinger, W; Berenson, R; Buckner, CD; Clift, R; Deeg, HJ; Pepe, M; Storb, R | 1 |
| Gordon, DS; Heffner, LT; Reynolds, RC; Vogler, WR; Winton, EF | 1 |
| Graves, T; Kampmann, KK; Rogers, SD | 1 |
| Bello, C; Bureo, E; Conde, E; Cuadrado, MA; Garijo, J; Hermosa, V; Iriondo, A; Pastor, JM; Recio, M; Richard, C | 1 |
| Devergie, A; Esperou, H; Gluckman, E; Lehn, P; Traineau, R; Varrin, F | 1 |
| Appelbaum, F; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R | 1 |
| Deeg, HJ; McGuire, TR; Self, SG; St Pierre, BA; Sullivan, KM; Yee, GC; Zager, RA | 1 |
| Aurer, I; Bogdanić, V; Labar, B; Mrsić, M; Nemet, D; Pavletić, Z; Radman, I; Zupancić, S | 1 |
| Bogdanić, V; Dobrić, I; Kastelan, A; Labar, B; Marusić, M; Mrsić, M; Nemet, D; Pavletić, Z; Plavsić, F; Zupancić-Salek, S | 1 |
| Hamajima, N; Horibe, K; Morishima, Y; Morishita, Y; Naito, K; Ohno, R; Saito, H; Tanimoto, M; Yamada, K; Yokomaku, S | 1 |
| Bäckman, L; Lönnqvist, B; Ringdén, O; Tollemar, J | 1 |
| Agostinelli, F; Angelucci, E; Baronciani, D; Delfini, C; Galimberti, M; Giorgi, C; Izzi, T; Lucarelli, G; Manna, M; Polchi, P | 1 |
| Appelbaum, FR; Buckner, CD; Cheever, MA; Clift, RA; Deeg, HJ; Doney, KC; Flournoy, N; Kennedy, MS; Storb, R; Thomas, ED | 1 |
| Sullivan, KM | 1 |
| Sanders, JE | 1 |
| Deeg, HJ; Raff, RF; Sale, GE; Severns, E; Storb, R | 1 |
| D'Amaro, J; De Gast, GC; Gratama, JW; Gratwohl, A; Jansen, J; Middeldorp, JM; Nissen, C; Speck, B; The, TH; Würsch, AM | 1 |
| Ford, D; Kwan, YL; Lam-Po-Tang, PR; Mameghan, H; O'Gorman-Hughes, DW; Vowels, MR; White, L; Ziegler, JB | 1 |
| Hoshi, N; Kato, S; Kimura, M; Muranaka, S; Nagasaka, M; Yabe, H | 1 |
| Dicke, KA; Weiner, RS | 1 |
| Santos, GW | 1 |
| Arnold, R; Bunjes, D; Heimpel, H; Heit, W; Hertenstein, B; Schmeiser, T; Wiesneth, M | 1 |
| Ashby, M; Atkinson, K; Biggs, JC; Concannon, A; Dodds, A; Downs, K | 1 |
| Gratecos, N; Guyotat, D; Hirn, J; Maraninchi, D; Mawas, C; Novakovitch, G; Reiffers, J; Vernant, JP | 1 |
| Blume, KG; Forman, SJ; Hill, LR; Krance, RA; Metter, GE; Miner, PJ; Nademanee, AP; O'Donnell, MR; Snyder, DS | 1 |
| Arthur, DC; Filipovich, AH; Kersey, JH; Kim, T; McGlave, P; Ramsay, NK | 1 |
| Appelbaum, F; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Fisher, L; Irle, C; McGuffin, R; Storb, R | 1 |
| Angelucci, E; Baronciani, D; Galimberti, M; Giardini, C; Lucarelli, G; Polchi, P; Politi, P | 1 |
| Carlin, J; Deeg, HJ; McGuire, TR; Sanders, JE; Self, SG; Yee, GC | 1 |
| Devergie, A; Gluckman, E; Lokiec, F | 1 |
| Heimdahl, A; Lönnqvist, B; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
| Hirabayashi, N; Iwamura, H; Kodera, Y; Matsuyama, K; Morishima, Y; Naito, K; Nakaide, Y; Yamada, H; Yano, K; Yokomaku, S | 1 |
| Boiron, M; Bombail, D; De Castro, H; Devergie, A; Gluckman, E; Huret, JL; Meletis, J; Traineau, R; Varrin, F; Vilmer, E | 1 |
| Arthur, D; Haake, R; Hurd, D; Kersey, J; Kim, T; McGlave, P; Miller, W; Ramsay, N; Vercellotti, G; Weisdorf, D | 1 |
| Appelbaum, FR; Deeg, HJ; Graham, TC; Sale, GE; Schuening, F; Storb, R; Thomas, ED | 1 |
| Clark, JG; Crawford, SW; Flournoy, N; Schwartz, DA; Sullivan, KM; Thomas, ED | 1 |
| Curtis, JE; Jamal, N; Lepine, J; Lockwood, G; Messner, HA; Minden, MD; Takahashi, T; Tritchler, D; Tweeddale, M; Wandl, U | 1 |
| Cavazzana, M; Cosset, JM; de Castro, H; Devergie, A; Gluckman, E; Lemercier, N; Lokiec, F; Meletis, J; Traineau, R; Varrin, F | 1 |
| Chen, KY; Chen, PM; Chiou, TJ; Chiu, CF; Chuang, MW; Hsien, RK; Tzeng, CH; Wang, SR; Wang, SY; Yung, CH | 1 |
| Bäckman, L; Bolme, P; Gahrton, G; Heimdahl, A; Lindholm, A; Lönnqvist, B; Ringdén, O | 1 |
| Bolme, P; Brattström, C; Gahrton, G; Johansen, L; Lönnqvist, B; Ringdén, O; Sundberg, B; Tollemar, J | 1 |
| Bortin, MM; Gale, RP; Gluckman, E; Hartz, AJ; Kay, HE; Kolb, HJ; Rimm, AA; Weiner, RS | 1 |
| D'Amaro, J; de Gast, GC; Gratama, JW; Gratwohl, A; Nissen, C; Speck, B; van Rood, JJ; Würsch, AM | 1 |
| Heidemann, E; Ostendorf, P; Schmidt, H; Schüch, K; Waller, HD | 1 |
| Appelbaum, F; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Farewell, V; Storb, R; Whitehead, J | 1 |
| Amos, D; Appelbaum, F; Deeg, HJ; Klosterman, A; Martin, P; Sale, G; Sanders, J; Shulman, H; Sullivan, KM; Witherspoon, R | 1 |
| Atkinson, K; Biggs, JC; Concannon, A; Dodds, A; Downs, K; Gillett, E | 1 |
| Ford, D; Hughes, DO; Lam-Po-Tang, R; Mameghan, H; Vowels, M | 1 |
| de Pauw, B; de Witte, T; Haanen, C; Holdrinet, R; Hoogenhout, J; Hustinx, T; Janssen, J; van Daal, W; Wessels, J | 1 |
| Fujimori, Y; Hara, H; Ifuku, H; Kai, S; Kanamaru, A; Kohsaki, M; Misawa, M; Ohe, Y; Okamoto, T; Shinohara, Y | 1 |
| Abbott, GD; Allen, JR; Beard, ME; Hart, DN; Heaton, DC; Heslop, HE | 1 |
| Appelbaum, F; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Farewell, V; Hansen, J; Storb, R | 1 |
| Barrett, AP | 1 |
| Biggs, JC; Ma, DD; Varga, DE | 1 |
| Appelbaum, FR; Beatty, P; Bensinger, W; Buckner, CD; Clift, RA; Deeg, HJ; Doney, K; Farewell, V; Storb, R; Whitehead, J | 1 |
| Inoue, S | 1 |
| Dahlberg, S; Deeg, HJ; Kennedy, MS; Loughran, TP; Storb, R; Thomas, ED | 1 |
| Beschorner, WE; Clark, AW; Patchell, RA; Santos, GW; White, CL | 1 |
| Lipton, J; Nathan, DG; Parkman, R; Rappeport, JM; Smith, BR | 1 |
| Bacigalupo, A; Chierichetti, S; Corbetta, G; Frassoni, F; Marmont, AM; Raffo, MR; van Lint, MT; Vitale, V | 1 |
| Appelbaum, FR; Banaji, M; Bensinger, WI; Buckner, CD; Clift, RA; Deeg, HJ; Flournoy, N; Kennedy, MS; Storb, R; Thomas, ED | 1 |
| Filipovich, AH; Goldman, A; Goldstein, G; Kersey, JH; Krawczak, CL; McGlave, P; Ramsay, NK | 1 |
| Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Flournoy, N; Lum, LG; Sanders, JE; Stewart, P; Sullivan, KM; Thomas, ED | 1 |
| Barcelo, R; Belanger, R; Boileau, J; Bonny, Y; David, M; Giasson, M; Gyger, M; Moquin, JP; Perreault, C | 1 |
| Brix, F; Dühmke, E; Euler, HH; Gassmann, W; Gremmel, H; Hebbinghaus, D; Kayser, W; Schaub, J; Schmitz, N; Wüstemann, M | 1 |
| Blume, KG; Findley, DO; Forman, SJ; Henke, M; Hill, LR; Krance, RA | 1 |
| Klingemann, HG; Storb, R | 1 |
| Appelbaum, FR; Beatty, P; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Irle, C; Kennedy, M; Storb, R | 1 |
| Jacobs, P | 1 |
| Gale, RP | 1 |
| Arranz, R; Fernández-Garese, D; Fernández-Rañada, JM; Fernández-Villalta, MJ; Gómez, N; Gómez-Reino, F; González, N; Lozano, M; Solano, C; Vázquez, L | 1 |
| Inoue, T; Masaoka, T; Nakamura, H; Shibata, H | 1 |
| Buckner, CD; Clift, RA; Fefer, A; Glucksberg, H; Lerner, KG; Neiman, PE; Storb, R; Thomas, ED | 1 |
| Epstein, RB; Graham, TC; Kolb, H; Kolb, HJ; Storb, R; Thomas, ED | 1 |
| Mathé, G; Schwarzenberg, L | 1 |
| Abeloff, MD; Anderson, PN; Bias, WB; Borgaonkar, DS; Braine, HG; Burke, PJ; Davis, TE; Humphrey, RL; Mullins, GM; Santos, GW; Sensenbrenner, LL; Slavin, RE; Tutschka, PJ | 1 |
| Lemmel, EM; Motycka, K; Nouza, K; Soucek, J | 1 |
| Erickson, V; Graham, TC; Kolb, H; Kolb, HJ; Lerner, KG; Mickelson, E; Rudolph, RH; Storb, R; Thomas, ED | 1 |
| Epstein, RB; Graham, TC; Storb, R; Thomas, ED | 1 |
| Chilgren, R; Gatti, R; Good, RA; Kersey, J; Meuwissen, HJ; Pabst, H | 1 |
| Floersheim, GL | 1 |
| Graham, TC; Kolb, H; Kolb, HJ; Storb, R; Thomas, ED | 1 |
| Graham, TC; Kolb, H; Kolb, HJ; Storb, R; Thomas, ED; Weiden, PL | 1 |
| Buckner, CD; Clift, RA; Fefer, A; Gluksberg, H; Lerner, KG; Neiman, PE; Storb, R; Thomas, ED | 1 |
| Buckner, CD; Clift, RA; Fefer, A; Lerner, KG; Neiman, PE; Storb, R; Thomas, ED | 1 |
| Rudolph, RH; Storb, R; Thomas, ED | 1 |
| Owens, AH; Santos, GW | 1 |
48 review(s) available for methotrexate and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Omission of day +11 methotrexate dose and allogeneic hematopoietic cell transplantation outcomes: results of a systematic review/meta-analysis.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Prospective Studies; Recurrence; Transplantation Conditioning | 2022 |
Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease.
Topics: Calcineurin Inhibitors; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Quality of Life | 2021 |
Multi-faceted role of LRP1 in the immune system.
Topics: Animals; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Low Density Lipoprotein Receptor-Related Protein-1; Methotrexate; Mice; T-Lymphocytes; Transplantation, Homologous | 2023 |
Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis.
Topics: Antilymphocyte Serum; Bortezomib; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2020 |
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
Topics: Age Factors; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Methotrexate; Risk Factors; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2021 |
[Recent developments in prophylaxis and treatment of graft-versus-host disease].
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; T-Lymphocytes; Transplantation, Homologous | 2021 |
Role of folinic acid in methotrexate-based prophylaxis of graft-versus-host disease following hematopoietic stem cell transplantation.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate; Vitamin B Complex | 2021 |
Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
Topics: Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous; Unrelated Donors | 2020 |
Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease--systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Mucositis; Mycophenolic Acid; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous | 2014 |
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Topics: Allografts; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2014 |
The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Topics: Busulfan; Cyclophosphamide; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Methotrexate; Mouth Mucosa; Myeloablative Agonists; Severity of Illness Index; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
[Graft-versus-host disease: friend or foe?].
Topics: Acute Disease; Cell Separation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 2008 |
Prophylaxis regimens for GVHD: systematic review and meta-analysis.
Topics: Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Risk; Tacrolimus; Treatment Outcome | 2009 |
Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?
Topics: Animals; Calcineurin Inhibitors; Controlled Clinical Trials as Topic; Enzyme Inhibitors; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate | 2010 |
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance.
Topics: Bias; Bone Marrow Transplantation; Data Interpretation, Statistical; Graft vs Host Disease; Humans; Intention to Treat Analysis; Methotrexate; Patient Compliance; Research Design; Selection Bias; Stem Cell Transplantation; Treatment Outcome | 2011 |
Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.
Topics: Biomarkers; Cord Blood Stem Cell Transplantation; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Prognosis; Tissue Donors | 2012 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
[GVHD].
Topics: Antilymphocyte Serum; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Muromonab-CD3; Photopheresis; Prednisolone; Prognosis; Tacrolimus | 2004 |
Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?
Topics: Alleles; Genetic Linkage; Genetic Predisposition to Disease; Genome; Genotype; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Iron; Liver; Lung Diseases; Mass Screening; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Models, Chemical; Oligonucleotide Array Sequence Analysis; Oxidants; Polymorphism, Genetic; Renal Insufficiency; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Cytotoxic and immunologic effects of methotrexate in psoriasis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Proliferation; DNA; Epidermal Cells; Epidermis; Graft vs Host Disease; Humans; Immune System; Methotrexate; Mice; Psoriasis | 1990 |
Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.
Topics: Bone Marrow Transplantation; Disease Management; Dose-Response Relationship, Drug; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Methotrexate; Odds Ratio; Peripheral Blood Stem Cell Transplantation; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Time Factors; Transplantation, Homologous | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
The pathophysiology and treatment of graft-versus-host disease.
Topics: Acute Disease; Animals; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Cytomegalovirus Infections; Graft vs Host Disease; Herpes Simplex; Histocompatibility; Humans; Immune Tolerance; Leukemia; Methotrexate; Mice; Prognosis; T-Lymphocytes | 1983 |
Immunologic, clinical, and pathologic aspects of human graft-versus-host disease.
Topics: Aged; Biopsy; Bone Marrow Transplantation; Drug Therapy, Combination; Globulins; Graft vs Host Disease; Histocompatibility Testing; Humans; Immune Tolerance; Infant, Newborn; Liver; Lymphocyte Activation; Lymphocytes; Methotrexate; Prednisone; Prognosis; Rectum; Risk; Skin; Time Factors | 1983 |
Bone marrow transplantation in acute nonlymphoblastic leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Piperazines; Prognosis; Recurrence; Whole-Body Irradiation | 1984 |
Acute graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Infant; Leukemia; Lymphocytes; Male; Methotrexate; Methylprednisolone; Middle Aged; Patient Isolation; Premedication; Time Factors; Transplantation, Homologous | 1983 |
Graft-versus-host disease: pathophysiological and clinical aspects.
Topics: Anemia, Aplastic; Animals; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immune Tolerance; Leukemia; Methotrexate; Patient Isolation; Prognosis; T-Lymphocytes; Transplantation, Homologous | 1984 |
Prevention and treatment of acute graft-versus-host disease.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporins; Glycine max; Graft Enhancement, Immunologic; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lectins; Lymphocyte Depletion; Methotrexate; Methylprednisolone; Plant Lectins; Ricin; Soybean Proteins; T-Lymphocytes | 1984 |
Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
Topics: Animals; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Dogs; Graft vs Host Disease; Graft vs Host Reaction; Histocompatibility Antigens; Leukocyte Transfusion; Lymphocyte Depletion; Methotrexate; Mice; Radiation Chimera | 1982 |
Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Purging; Bone Marrow Transplantation; Child; Child, Preschool; Cohort Studies; Fanconi Anemia; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Incidence; Infant; Life Tables; Male; Methotrexate; Middle Aged; Pneumonia; Proportional Hazards Models; Risk; Survival Analysis | 1993 |
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors | 1993 |
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Topics: Adult; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Disease Progression; Dogs; Forecasting; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Methotrexate; Middle Aged; Mycophenolic Acid; Neoplasms; Prednisone; Radiation Chimera; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2001 |
New developments in the prophylaxis and treatment of graft versus host disease.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Differentiation; Antimetabolites; Bone Marrow Transplantation; CD40 Ligand; Clinical Trials as Topic; CTLA-4 Antigen; Cyclosporine; Drug Design; Graft vs Host Disease; Guanidines; Guidelines as Topic; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Mycophenolic Acid; Sirolimus; T-Lymphocytes; Tacrolimus | 2001 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2001 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
Allogeneic bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Survival Analysis; Transplantation, Homologous | 1991 |
[Prevention and treatment of acute graft-versus host disease].
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antilymphocyte Serum; Cyclosporins; Graft vs Host Disease; Humans; Incidence; Lymphocyte Depletion; Methotrexate; Receptors, Interleukin-2; Tumor Necrosis Factor-alpha | 1991 |
Granulocytic sarcoma of the ileum treated by bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Graft vs Host Disease; Humans; Ileal Neoplasms; Leukemia, Myeloid; Male; Methotrexate; Remission Induction; Whole-Body Irradiation | 1991 |
Human graft-versus-host disease.
Topics: Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; HLA Antigens; Humans; Immunocompetence; Leukemia, Lymphoid; Methotrexate; T-Lymphocytes | 1991 |
Canine models of bone marrow transplantation.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporins; Disease Models, Animal; Dogs; Graft Enhancement, Immunologic; Graft vs Host Disease; Immunosuppression Therapy; Methotrexate; Models, Biological | 1990 |
Pulmonary disease in the immunocompromised host. 1.
Topics: Acquired Immunodeficiency Syndrome; Biopsy; Bleomycin; Bone Marrow Transplantation; Connective Tissue Diseases; Graft vs Host Disease; Hemorrhage; Humans; Immune Tolerance; Kidney Failure, Chronic; Kidney Transplantation; Leukemia; Leukocyte Count; Lung Diseases; Lung Neoplasms; Lymphoma; Methotrexate; Pulmonary Fibrosis; Radiography; Recurrence; Sarcoma, Kaposi; Transplantation Immunology | 1985 |
Acute and chronic graft-versus-host disease in man.
Topics: Acute Disease; Age Factors; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Immune Tolerance; Immunosuppression Therapy; Infections; Methotrexate; Prednisolone; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 1986 |
Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Transplantation Immunology; Virus Diseases | 1988 |
[Bone marrow transplantation in pediatric patients: review of progress].
Topics: Anemia, Aplastic; Blast Crisis; Bone Marrow Transplantation; Busulfan; Child; Cyclosporins; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Methotrexate; Preoperative Care; Prognosis | 1987 |
Graft-versus-host disease.
Topics: Acute Disease; Animals; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclosporins; Diseases in Twins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Prognosis; Pulmonary Fibrosis; Risk; T-Lymphocytes; Twins, Monozygotic | 1985 |
210 trial(s) available for methotrexate and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Female; Germany; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Tacrolimus; Time Factors; Transplantation Conditioning; United States; Young Adult | 2022 |
Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy.
Topics: Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Methotrexate; Sphingosine-1-Phosphate Receptors | 2023 |
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchiolitis Obliterans Syndrome; Cyclophosphamide; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus; Unrelated Donors | 2023 |
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Topics: Enzyme Inhibitors; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Mucositis; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus | 2023 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Reported Outcome Measures; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2020 |
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Prospective Studies; Stem Cell Transplantation; Treatment Outcome | 2021 |
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study.
Topics: Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate | 2020 |
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Stomatitis; Tacrolimus | 2021 |
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Placebo Effect; Transplantation, Homologous; Treatment Outcome | 2021 |
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.
Topics: Adolescent; Adult; Allografts; Cord Blood Stem Cell Transplantation; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Registries; Retrospective Studies | 2021 |
Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention.
Topics: Adult; Aged; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Sirolimus; Survival Rate; Tacrolimus | 2017 |
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
Topics: Adult; Aged; Allografts; Atorvastatin; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Prospective Studies; Survival Rate; Tacrolimus | 2017 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Male; Methotrexate; Middle Aged; T-Lymphocytes; Time Factors; Treatment Outcome; Young Adult | 2017 |
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.
Topics: Acetylation; Acute Disease; Adolescent; Adult; Aged; Demography; Feasibility Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Incidence; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Tacrolimus; Transplantation Conditioning; Unrelated Donors; Vorinostat; Young Adult | 2017 |
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Tacrolimus; Young Adult | 2017 |
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lower Gastrointestinal Tract; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation Conditioning; Young Adult | 2018 |
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Sirolimus; Survival Rate; Tacrolimus; Unrelated Donors | 2019 |
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Topics: Adult; Aged; Allografts; Calcineurin Inhibitors; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Retrospective Studies; Siblings; Survival Rate; Tacrolimus; Transplantation Conditioning | 2019 |
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Antigens, CD34; Bone Marrow Cells; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Rate; T-Lymphocyte Subsets; Transplantation Conditioning | 2019 |
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Topics: Adenosine Deaminase Inhibitors; Adult; Antibodies, Monoclonal; Area Under Curve; Blood Transfusion, Autologous; Creatinine; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infliximab; Lymphocyte Transfusion; Male; Methotrexate; Methylprednisolone; Middle Aged; Pentostatin; Renal Insufficiency; Stem Cell Transplantation; Tacrolimus; Young Adult | 2013 |
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
Topics: Adult; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Siblings; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2013 |
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.
Topics: Adolescent; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sirolimus; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2014 |
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.
Topics: Adolescent; Adult; Allografts; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Sirolimus; Stomatitis; Survival Rate; Tacrolimus; Time Factors | 2014 |
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Transplantation Conditioning; Young Adult | 2014 |
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Myeloablative Agonists; Prospective Studies; Tacrolimus; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2014 |
Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency.
Topics: Adolescent; Adult; Busulfan; Child; Female; Graft Survival; Graft vs Host Disease; Guanine Nucleotide Exchange Factors; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunophenotyping; Immunosuppressive Agents; Male; Methotrexate; Mutation; Myeloablative Agonists; Pilot Projects; Severe Combined Immunodeficiency; Siblings; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2015 |
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Chronic Disease; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Severity of Illness Index; Siblings; Sirolimus; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2015 |
Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma.
Topics: Adult; Aged; Allografts; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Sirolimus; Stem Cell Transplantation; Survival Rate; Tacrolimus; Vidarabine | 2015 |
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Topics: Adult; Aged; Allografts; Anti-Inflammatory Agents; Cannabidiol; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult | 2015 |
A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
Topics: Adult; Bortezomib; Busulfan; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Survival Analysis; Tacrolimus; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2015 |
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Topics: Acute Disease; Adolescent; Adult; Allografts; Child; Child, Preschool; Cyclosporine; Europe; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Incidence; Male; Methotrexate; Middle East; Neutropenia; Retrospective Studies; Societies, Medical; Unrelated Donors | 2015 |
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncolo
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Allografts; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Methotrexate; Middle Aged; Stem Cell Transplantation; Tacrolimus; Time Factors; Transplantation Conditioning | 2016 |
The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Topics: Adolescent; Adult; Aged; Allografts; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Sirolimus; Tacrolimus; Transplantation Conditioning | 2016 |
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Premedication; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2016 |
Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.
Topics: Adolescent; Adult; Allografts; Area Under Curve; Biomarkers, Tumor; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; ROC Curve; Sensitivity and Specificity; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult | 2017 |
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.
Topics: Adult; Allografts; Antibodies, Monoclonal, Humanized; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Middle Aged; Tacrolimus; Unrelated Donors | 2017 |
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Premedication; Sirolimus; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.
Topics: Acute Disease; Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cause of Death; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Methotrexate; Middle Aged; Tacrolimus; Treatment Outcome; Young Adult | 2009 |
First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Transplantation, Homologous | 2009 |
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Administration, Oral; Adult; Age Factors; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Sex Factors; Sirolimus; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Living Donors; Male; Methotrexate; Pyrazines; Stem Cell Transplantation; Survival Rate; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2009 |
A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).
Topics: Adolescent; Child; Child, Preschool; Epidemiologic Methods; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Sirolimus; Tacrolimus; Treatment Outcome; Young Adult | 2009 |
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Topics: Adult; Aged; Animals; Anti-Infective Agents; Antilymphocyte Serum; Busulfan; Disease Susceptibility; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infection Control; Infections; Male; Medical Audit; Methotrexate; Middle Aged; Myeloablative Agonists; Patient Isolation; Postoperative Complications; Rabbits; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2009 |
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prognosis; Stem Cell Transplantation; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Disease Progression; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Melphalan; Methotrexate; Middle Aged; Mycosis Fungoides; Myeloablative Agonists; Recurrence; Sezary Syndrome; Tacrolimus; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult | 2010 |
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Survival Rate; Treatment Outcome | 2011 |
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Living Donors; Lymphoma, Follicular; Male; Methotrexate; Middle Aged; Remission Induction; Rituximab; Salvage Therapy; Siblings; Tacrolimus; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2011 |
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
Topics: Adenosine Deaminase Inhibitors; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Male; Methotrexate; Middle Aged; Pentostatin; Survival Analysis; Tacrolimus; Transplantation Conditioning | 2011 |
Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Cell Survival; Child; Child, Preschool; China; Combined Modality Therapy; Cyclosporine; Female; Filgrastim; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Histocompatibility Testing; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
Higher CD3(+) and CD34(+) cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antigens, CD34; Bone Marrow Transplantation; Busulfan; CD3 Complex; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Methylprednisolone; Myeloablative Agonists; Siblings; Thalassemia; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2011 |
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis.
Topics: Adolescent; Adult; Child; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-G Antigens; Humans; Immunosuppressive Agents; INDEL Mutation; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 2012 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Chronic Disease; Combined Modality Therapy; Drug Resistance; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Methotrexate; Middle Aged; Morbidity; Steroids; Survival Analysis; Young Adult | 2012 |
[Comparison study on treatment of acute graft-versus-host disease with low-dose methotrexate in combination with low-dose methylprednisolone or standard-dose methylprednisolone].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Young Adult | 2011 |
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Case-Control Studies; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Quality of Life; Sirolimus; Survival Rate; T-Lymphocytes, Regulatory; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2012 |
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
Topics: Adult; Aged; Antilymphocyte Serum; Boronic Acids; Bortezomib; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Pyrazines; Tacrolimus; Unrelated Donors | 2012 |
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Pilot Projects; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult | 2011 |
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Prospective Studies; Risk; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation | 2013 |
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilization; Erythrocyte Transfusion; Female; Fever; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Home Nursing; Hospitalization; Humans; Immunosuppressive Agents; Infection Control; Male; Methotrexate; Middle Aged; Pancytopenia; Parenteral Nutrition, Total; Patient Care Team; Patient Isolation; Prednisolone; Quality of Life; Recurrence; Survival Rate; Sweden; Transplantation Conditioning; Treatment Outcome | 2002 |
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Longitudinal Studies; Male; Methotrexate; Mycoses; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Topics: Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Sirolimus; Survival Rate; Tacrolimus; Tissue Donors | 2003 |
Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japa
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Infant; Japan; Male; Methotrexate; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2003 |
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; CD3 Complex; Cell Separation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma.
Topics: Adult; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Risk Factors; Survival Rate; Tacrolimus; Transplantation, Homologous | 2003 |
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infant; Male; Methotrexate; Risk Factors; Tissue Donors | 2003 |
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors.
Topics: Adult; Blood Donors; Cyclosporine; Cytomegalovirus; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Virus Activation | 2004 |
Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.
Topics: Adolescent; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hepatomegaly; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Methotrexate; Remission Induction; Risk Factors; Survival Analysis; Transplantation, Homologous | 2004 |
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Pentostatin; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2004 |
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial.
Topics: Adolescent; Adult; Child; Drug Resistance; Female; Graft vs Host Disease; Hepatic Artery; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Male; Methotrexate; Methylprednisolone; Renal Insufficiency | 2004 |
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Topics: Adult; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sirolimus; Survival Analysis; Tacrolimus; Treatment Outcome | 2004 |
Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Topics: Acute Disease; Adult; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Multivariate Analysis; Risk Factors; Secondary Prevention; Survival Rate; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2004 |
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2004 |
Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Premedication; Treatment Outcome | 2005 |
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate | 2005 |
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Methotrexate; Premedication; Prevalence; Survival Analysis | 2005 |
Outcome of pediatric hematopoietic stem cell transplantations from Thai unrelated donors matched with high-resolution HLA typing.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; DNA Fingerprinting; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Premedication; Risk Factors; Survival Analysis; Thailand; Tissue Donors; Treatment Failure; Treatment Outcome | 2005 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.
Topics: Adult; Antilymphocyte Serum; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Risk Factors; Tacrolimus; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2007 |
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sirolimus; Survival Rate; Tacrolimus; Tissue Donors; Transplantation Conditioning | 2007 |
Serologically HLA-DR-mismatched unrelated donors might provide a valuable alternative in allogeneic transplantation: experience from a single japanese institution.
Topics: Adolescent; Adult; Aged; Asian People; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; HLA-DR Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Tacrolimus; Transplantation, Homologous | 2007 |
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Haplotypes; Histocompatibility; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Mitoxantrone; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Tissue Donors; Treatment Outcome | 2007 |
Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation.
Topics: Adolescent; Adult; Affect; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Physical Fitness; Psychology; Self Efficacy; Social Support | 2007 |
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Living Donors; Methotrexate; Methylprednisolone; Mycophenolic Acid; Myeloablative Agonists; Postoperative Complications; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2008 |
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host
Topics: Adolescent; Adult; Aspergillosis; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Lymphocyte Depletion; Male; Methotrexate; Opportunistic Infections; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2007 |
Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Logistic Models; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors | 2007 |
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
Topics: Adolescent; Adult; Bone Density; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2008 |
Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.
Topics: Adult; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Calcineurin Inhibitors; Case-Control Studies; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Virus Activation | 2008 |
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning | 2008 |
High dose bolus methylprednisolone for the treatment of acute graft versus host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Delayed-Action Preparations; Female; Graft vs Host Disease; Histocompatibility; Humans; Intestines; Liver; Male; Methotrexate; Methylprednisolone; Middle Aged; Skin | 1983 |
Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
Topics: Adult; Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Clinical Trials as Topic; Graft vs Host Disease; Horses; Humans; Immunosuppression Therapy; Leukemia; Male; Methotrexate; Prednisolone; Rabbits; Random Allocation; T-Lymphocytes; Transplantation, Homologous | 1981 |
Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glycosylation; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Histocompatibility; HLA Antigens; Humans; Injections, Subcutaneous; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Tissue Donors | 1994 |
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Tacrolimus; Tissue Donors | 1995 |
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft vs Host Disease; Histocompatibility Testing; Humans; Kidney; Male; Methotrexate; Methylprednisolone; Middle Aged; Pilot Projects; Survival Analysis; Tacrolimus; Transplantation, Homologous | 1995 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Aspergillosis; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Fungemia; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Male; Methotrexate; Polymorphism, Restriction Fragment Length | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
Bone marrow transplantation for Fanconi anemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Male; Methotrexate; Survival Rate | 1995 |
Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Prospective Studies; Receptors, Interleukin-2; T-Lymphocytes | 1995 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; T-Lymphocytes | 1994 |
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Male; Methotrexate; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors | 1994 |
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Recurrence; Survival Analysis; T-Lymphocytes; Time Factors | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Prospective Studies | 1994 |
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Prednisolone; Transplantation, Homologous | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Edema; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunotoxins; Infant; Male; Methotrexate; Prednisolone; Ricin; Tissue Donors; Weight Gain | 1993 |
Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.
Topics: Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Prognosis | 1993 |
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Fever; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Pentoxifylline; Placebos; Probability; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International
Topics: Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Probability; Proportional Hazards Models; Regression Analysis | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis | 1995 |
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation, Homologous | 1996 |
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Topics: Adult; Aged; Antigens, CD34; Blood Cells; Cell Count; Cell Separation; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
Topics: Actuarial Analysis; Administration, Oral; Adult; Anemia, Refractory, with Excess of Blasts; Bone Marrow Transplantation; Creatinine; Disease-Free Survival; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Diseases; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Salvage Therapy; Survival Analysis; Tacrolimus; Transplantation Conditioning | 1996 |
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; T-Lymphocytes; Time Factors; Transcription, Genetic; Transplantation Chimera | 1997 |
The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Infections; Kidney Diseases; Life Tables; Liver Diseases; Male; Methotrexate; Middle Aged; Pilot Projects; Safety; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1997 |
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Child; Drug Interactions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Tacrolimus; Transplantation, Homologous | 1997 |
Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Transplantation Conditioning | 1997 |
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Karnofsky Performance Status; Methotrexate; Multivariate Analysis; Recurrence; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Failure | 1997 |
Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
Topics: Adult; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia; Male; Methotrexate; Middle Aged; Nuclear Family; Tissue Donors; Transplantation, Homologous | 1997 |
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 1997 |
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Topics: Adolescent; Anemia, Sickle Cell; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Methotrexate; Transplantation Chimera; Transplantation Conditioning | 1997 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord.
Topics: Anemia, Sickle Cell; Antineoplastic Agents, Alkylating; beta-Thalassemia; Child; Child, Preschool; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prospective Studies; Thiotepa; Treatment Outcome | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Methotrexate; Multivariate Analysis; Prognosis; Time Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Combined Modality Therapy; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Immunomagnetic Separation; Immunosuppressive Agents; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1999 |
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Topics: Adolescent; Adult; Anti-Infective Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Infant; Male; Methotrexate; Metronidazole; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1999 |
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cause of Death; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Prospective Studies; Recurrence; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation.
Topics: Antimetabolites, Antineoplastic; Child; Child, Preschool; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Tacrolimus; Tissue Donors; Transplantation Conditioning | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemoglobinuria, Paroxysmal; Hepatitis Antigens; Hepatitis, Viral, Human; Histocompatibility; Humans; Male; Methotrexate; Nuclear Family; Quality of Life; Transplantation Conditioning; Virus Activation | 2000 |
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Topics: Acute Disease; Adenoviridae Infections; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Fungemia; Ganciclovir; Graft vs Host Disease; Histocompatibility; Humans; Immunomagnetic Separation; Immunosuppressive Agents; Leukemia; Lung Diseases, Interstitial; Lymphocyte Depletion; Male; Methotrexate; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisolone; Safety; Survival Rate; Tissue Donors | 2000 |
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Topics: Adolescent; Adult; Bone Marrow Cells; Cyclosporine; Family; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Living Donors; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Primary Myelofibrosis; Survival Analysis; Transplantation, Homologous | 2000 |
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2000 |
[Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Premedication; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nuclear Family; Survival Analysis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2000 |
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Analysis; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation Tolerance; Vidarabine | 2000 |
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infection Control; Italy; Life Tables; Male; Methotrexate; Middle Aged; Rabbits; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Female; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Male; Methotrexate; Middle Aged; Platelet Transfusion; Recurrence; Remission Induction; Rituximab; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Mycophenolic Acid; Transplantation, Heterologous; Young Adult | 2001 |
[A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sibling Relations; Stem Cells; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation | 2001 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Melphalan; Methotrexate; Transplantation, Autologous; Transplantation, Homologous | 1992 |
Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.
Topics: Actuarial Analysis; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Whole-Body Irradiation | 1992 |
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukemia; Methotrexate | 1992 |
Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Radiation; Female; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung; Lung Diseases; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Radiation Protection; Transplantation, Homologous; Whole-Body Irradiation | 1992 |
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors | 1992 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Italy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Rate; Whole-Body Irradiation | 1991 |
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).
Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Prospective Studies; Receptors, Interleukin-2; Transplantation, Homologous | 1991 |
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Life Tables; Methotrexate; Radiotherapy Dosage; Survival Analysis; Transplantation, Homologous; Washington; Whole-Body Irradiation | 1991 |
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporins; Drug Evaluation; Female; Fever; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hodgkin Disease; Humans; Infection Control; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins | 1991 |
Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Risk Factors; Spleen; Splenectomy; T-Lymphocytes | 1991 |
Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors | 1991 |
Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporins; Graft vs Host Disease; Humans; Methotrexate; Neoplasms | 1991 |
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Topics: Adult; Blood Transfusion; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Infections; Leukemia; Lymphocyte Depletion; Methotrexate; T-Lymphocytes | 1991 |
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Topics: Acute Disease; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Leukemia; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Random Allocation; Risk Factors; Whole-Body Irradiation | 1990 |
Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Transplantation, Homologous | 1990 |
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Transplantation, Autologous; Whole-Body Irradiation | 1990 |
Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia. International Bone Marrow Transplant Registry.
Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Drug Evaluation; Graft vs Host Disease; Humans; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 1989 |
Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Blood Transfusion; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Recurrence | 1989 |
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunotherapy; Infant; Leukemia; Leukocytes; Lymphoma; Male; Methotrexate; Pulmonary Fibrosis; Recurrence | 1989 |
Results of four different protocols for prophylaxis against graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Lymphoma; Methotrexate; Postoperative Complications; Random Allocation; Recurrence; T-Lymphocytes | 1989 |
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Methotrexate; Prognosis; Time Factors | 1989 |
Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Evaluation; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Methotrexate; Random Allocation | 1989 |
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Random Allocation; Time Factors | 1989 |
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
Topics: Bone Marrow Transplantation; Creatinine; Cyclosporins; Drug Administration Schedule; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Randomized Controlled Trials as Topic | 1989 |
Allogeneic BMT for AML in Zagreb.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Randomized Controlled Trials as Topic | 1989 |
Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Randomized Controlled Trials as Topic; Transplantation, Homologous | 1989 |
An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cataract; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Infant; Kidney; Liver; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Random Allocation | 1988 |
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Cyclosporins; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation; Recurrence | 1985 |
A prospective randomised trial of cyclosporin versus methotrexate after HLA-identical sibling marrow transplantation for patients with acute leukemia in first remission: analysis 2.5 years after last patient entry.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Cyclosporins; Female; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Random Allocation; Remission Induction | 1988 |
A prospective randomized study of acute graft-v-host disease in 107 patients with leukemia: methotrexate/prednisone v cyclosporine A/prednisone.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Prednisone; Prospective Studies | 1987 |
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Prognosis; Prospective Studies; Pulmonary Fibrosis | 1988 |
A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Cyclosporins; Female; Graft Survival; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Mouth Diseases; Random Allocation; Recurrence | 1986 |
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation | 1986 |
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Pulmonary Fibrosis; Random Allocation; Transplantation, Homologous | 1986 |
A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Random Allocation | 1986 |
Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate | 1986 |
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate | 1987 |
Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Female; Glucocorticoids; Graft vs Host Disease; Humans; Hypertension; Male; Methotrexate; Middle Aged; Postoperative Period | 1985 |
Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Cyclosporins; Depression; Graft vs Host Disease; Humans; Hypertension; Kidney Diseases; Length of Stay; Leukemia; Liver Diseases; Methotrexate; Middle Aged; Mycoses; Pulmonary Fibrosis; Random Allocation | 1985 |
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
Topics: Adult; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Kidney Diseases; Leukemia; Liver Diseases; Methotrexate; Middle Aged; Recurrence; Vascular Diseases; Whole-Body Irradiation | 1985 |
Graft-versus-host disease.
Topics: Acute Disease; Animals; Bone Marrow Transplantation; Chronic Disease; Clinical Trials as Topic; Cyclosporins; Diseases in Twins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Prognosis; Pulmonary Fibrosis; Risk; T-Lymphocytes; Twins, Monozygotic | 1985 |
454 other study(ies) available for methotrexate and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation.
Topics: Adrenal Cortex Hormones; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Transplantation Conditioning | 2022 |
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mucositis; Retrospective Studies; Transplantation, Homologous | 2022 |
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4
Topics: Animals; Cell Proliferation; Cyclophosphamide; Cytarabine; Forkhead Transcription Factors; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Methotrexate; Mice; T-Lymphocytes, Regulatory | 2022 |
Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch.
Topics: Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Ligands; Methotrexate; Mycophenolic Acid; Receptors, KIR; Recurrence; Retrospective Studies | 2022 |
Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.
Topics: Clinical Trials as Topic; Diterpenes; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Prospective Studies; Tacrolimus | 2022 |
Chronic Nodular Prurigo: A Retrospective Study of 74 Cases.
Topics: Adrenal Cortex Hormones; Female; Graft vs Host Disease; Histamine Antagonists; Humans; Immunoglobulin E; Male; Methotrexate; Middle Aged; Neurodermatitis; Prurigo; Pruritus; Retrospective Studies | 2022 |
Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation.
Topics: Cyclosporine; Drug Tapering; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Retrospective Studies | 2023 |
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant.
Topics: Antilymphocyte Serum; Cyclophosphamide; Graft vs Host Disease; Humans; Methotrexate; Prospective Studies; Tacrolimus; Unrelated Donors | 2022 |
Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
Topics: Cyclophosphamide; Graft vs Host Disease; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Tacrolimus | 2022 |
Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate.
Topics: Encephalitis; Female; Graft vs Host Disease; Humans; Leukoencephalopathies; Male; Methotrexate; Middle Aged; White Matter | 2022 |
Donor-derived diffuse large B-cell lymphoma after haploidentical stem cell transplantation for acute myeloid leukemia.
Topics: Antilymphocyte Serum; Azacitidine; Busulfan; Epstein-Barr Virus Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; HLA Antigens; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Tacrolimus; Transplantation Conditioning | 2022 |
Haploidentical transplant for paediatric patients with severe thalassaemia using post-transplant cyclophosphamide and methotrexate: A prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China.
Topics: Bone Marrow Failure Disorders; Bronchiolitis Obliterans Syndrome; Child; China; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Pancytopenia; Thalassemia; Transplantation Conditioning; Transplantation, Haploidentical | 2023 |
Significance of Omitting Day 11 Mini-Dose Methotrexate for GVHD Prophylaxis After Unrelated Bone Marrow Transplantation.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Methotrexate; Retrospective Studies; Transplantation, Homologous | 2023 |
Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation.
Topics: Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2023 |
Factors Affecting Day-to-Day Variations in Tacrolimus Concentration among Children and Young Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Carcinoma, Renal Cell; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Methotrexate; Retrospective Studies; Tacrolimus; Young Adult | 2023 |
A Calcineurin Inhibitor Free Graft Versus Host Disease Prophylaxis for Patients Undergoing Matched Related and Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplant.
Topics: Calcineurin; Calcineurin Inhibitors; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Unrelated Donors | 2023 |
Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis.
Topics: Allografts; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2023 |
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning.
Topics: Cryotherapy; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Retrospective Studies; Stomatitis; Transplantation Conditioning | 2023 |
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning.
Topics: Busulfan; Graft vs Host Disease; Humans; Methotrexate; Primary Myelofibrosis; Recurrence; Tacrolimus | 2023 |
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Topics: Acetyl-CoA C-Acetyltransferase; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Japan; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Recurrence; Siblings; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2020 |
Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus.
Topics: Aged; Brain Diseases; Central Nervous System Diseases; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Myelodysplastic Syndromes; Myoclonus; Pulse Therapy, Drug; Transplantation, Homologous | 2019 |
GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.
Topics: Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 2020 |
Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Topics: Adolescent; Anemia, Diamond-Blackfan; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Prospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2019 |
The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Allografts; Autografts; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning | 2020 |
Haploidentical stem cell transplant with post-transplantation cyclophosphamide and mini-dose methotrexate in children.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Male; Methotrexate; Retrospective Studies; Survival Rate; Transplantation Conditioning; Unrelated Donors | 2020 |
A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Liver Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisolone; Splenic Neoplasms; Tacrolimus; Transplantation, Haploidentical; Treatment Outcome; Vincristine | 2020 |
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Oligopeptides; Transplantation Conditioning; Unrelated Donors | 2021 |
Treatment of graft versus host disease with methotrexate after allogeneic hematopoietic stem cell transplantation.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Tacrolimus | 2021 |
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Young Adult | 2021 |
The stability of initial tacrolimus concentration following allogeneic hematopoietic stem cell transplantation reduces the risk of acute GVHD.
Topics: Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Retrospective Studies; Tacrolimus | 2020 |
Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Disease-Free Survival; Female; Glycopeptides; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Young Adult | 2021 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survi
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclophosphamide; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Retrospective Studies; Severity of Illness Index; Siblings; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation | 2017 |
Current Use and Trends in Hematopoietic Cell Transplantation in the United States.
Topics: Adult; Alemtuzumab; Antilymphocyte Serum; Calcineurin Inhibitors; Child; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility Testing; Humans; Methotrexate; Myeloablative Agonists; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous | 2017 |
Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.
Topics: Adolescent; Allografts; Bone Marrow Transplantation; Calcineurin Inhibitors; Child; Child, Preschool; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Infant; Male; Methotrexate; Neoplasms; Retrospective Studies; Siblings; Tissue Donors | 2018 |
T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Young Adult | 2018 |
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Exosomes; Female; Gene Expression Profiling; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; MicroRNAs; Middle Aged; Myeloablative Agonists; ROC Curve; Survival Analysis; Tacrolimus; Transplantation, Homologous | 2018 |
Establishment of immunity against Epstein-Barr virus infection in a patient with CHARGE/complete DiGeorge syndrome after peripheral blood lymphocyte transfusion.
Topics: CD3 Complex; Cell Proliferation; CHARGE Syndrome; Concanavalin A; Cyclosporine; Diarrhea; DiGeorge Syndrome; Epstein-Barr Virus Infections; Fatal Outcome; Graft vs Host Disease; Herpesvirus 4, Human; HLA Antigens; Humans; Infant, Newborn; Lymphocyte Transfusion; Male; Methotrexate; Mutation; Phenotype; Phytohemagglutinins; Siblings; T-Lymphocytes | 2019 |
Tacrolimus Levels in the Prophylaxis of Acute Graft-Versus-Host Disease in the Chinese Early After Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Asian People; Child; Child, Preschool; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2019 |
Acral erythema worsened by intravenous infusions of cyclosporin.
Topics: Adult; Antineoplastic Agents; Cyclosporine; Cytarabine; Drug Eruptions; Erythema; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2013 |
[Methotrexate treatment in severe chronic ocular graft versus host disease (GvHD)].
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome | 2013 |
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
Topics: Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Busulfan; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Transfusion; Male; Methotrexate; Middle Aged; Pilot Projects; Secondary Prevention; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2013 |
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Topics: Academies and Institutes; Anti-Infective Agents; Cyclosporine; Data Collection; Graft vs Host Disease; Growth Hormone; Hematopoietic Stem Cell Transplantation; Humans; Mediterranean Region; Methotrexate; Pulmonary Veno-Occlusive Disease; Transplantation, Autologous; Transplantation, Homologous; Ursodeoxycholic Acid | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult | 2013 |
Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Injections, Intravenous; Male; Methotrexate; Neutropenia; Retrospective Studies; Steroids; Treatment Outcome | 2014 |
Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Female; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Middle Aged; Vidarabine; Young Adult | 2014 |
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Busulfan; Chimerism; Cohort Studies; Cyclophosphamide; Cyclosporine; Cytomegalovirus Infections; DNA; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; T-Lymphocytes; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Viremia; Young Adult | 2014 |
[Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective].
Topics: Adolescent; Child; Child, Preschool; Female; Graft vs Host Disease; Haploidy; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning | 2014 |
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Sirolimus; Tacrolimus; Thrombotic Microangiopathies; Transplantation, Homologous; Young Adult | 2014 |
On a class of optimal covariate-adjusted response adaptive designs for survival outcomes.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Research Design; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant.
Topics: Adult; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Sirolimus; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Young Adult | 2015 |
Tailoring the GVHD prophylaxis regimen according to transplantation associated toxicities-Substituting the 3rd dose of methotrexate to mycophenolate mofetil.
Topics: Adult; Aged; Drug Administration Schedule; Drug Substitution; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Survival Analysis; Transplantation Conditioning; Young Adult | 2014 |
Sirolimus plus calcineurin inhibitors and methotrexate: is more necessarily better?
Topics: Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Sirolimus; Tacrolimus; Transplantation Conditioning; Unrelated Donors | 2015 |
[The outcome of thirteen patients with nonmalignant hematologic diseases treated with HLA haploidentical stem cell transplantation].
Topics: Anemia, Aplastic; Busulfan; Graft vs Host Disease; Hematologic Diseases; Histocompatibility; HLA Antigens; Humans; Incidence; Methotrexate; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2014 |
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Female; Graft Survival; Graft vs Host Disease; Haplotypes; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Survival Analysis; Tacrolimus; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2015 |
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2015 |
[Therapeutic efficacy of second allo-HSCT for aplastic anemia after failure of first allo-HSCT].
Topics: Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
Folinic acid after MTX as prophylaxis for GVHD in pediatric bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Infant, Newborn; Leucovorin; Male; Methotrexate; Patient Outcome Assessment; Premedication; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2015 |
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Retrospective Studies; Severity of Illness Index; Siblings; Treatment Outcome; Young Adult | 2015 |
Successful treatment with allogenic hematopoietic stem cell transplantation of a severe congenital neutropenia patient harboring a novel ELANE mutation.
Topics: Allografts; Congenital Bone Marrow Failure Syndromes; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukocyte Elastase; Male; Methotrexate; Mutation, Missense; Neutropenia; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2014 |
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Outcome Assessment, Health Care; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Survival Analysis; Transplantation Conditioning; Unrelated Donors; Vidarabine; Young Adult | 2015 |
[Efficacies of hematopoietic stem cell transplantation for severe aplastic anemia: a report of 43 patients].
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Siblings; Transplantation Conditioning; Vidarabine; Young Adult | 2014 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma.
Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents; Busulfan; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2015 |
CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.
Topics: Acute Disease; Adult; Aged; Allografts; Aminosalicylic Acids; Benzenesulfonates; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Dendritic Cells; Female; Glucocorticoids; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Male; Methotrexate; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Peripheral Blood Stem Cell Transplantation; Phosphorylation; Prospective Studies; Protein Processing, Post-Translational; Receptors, Interleukin-6; Sirolimus; STAT3 Transcription Factor; Th17 Cells; TOR Serine-Threonine Kinases | 2015 |
[Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
Topics: Biomedical Research; Blood Platelets; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Medicine, Chinese Traditional; Methotrexate; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2015 |
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Transplantation, Homologous; Young Adult | 2015 |
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Topics: Age Factors; Anemia, Aplastic; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2015 |
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study.
Topics: Adult; Aged; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
[Prophylaxis of acute graft-versus-host disease].
Topics: Acute Disease; Allografts; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate | 2015 |
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.
Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
Topics: Adolescent; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Male; Methotrexate; Neoplasms; Neutrophils; Retrospective Studies; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome | 2016 |
Cytomegalovirus Encephalitis in a Patient with Severe Combined Immunodeficiency.
Topics: Antibodies, Viral; Antigens, Viral; Cells, Cultured; Cord Blood Stem Cell Transplantation; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Encephalitis; Ganciclovir; Graft vs Host Disease; HLA-DRB1 Chains; Humans; Infant; Interferon-gamma; Interleukin Receptor Common gamma Subunit; Male; Methotrexate; Severe Combined Immunodeficiency | 2015 |
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
Topics: Aurora Kinase A; Gene Expression; Graft vs Host Disease; Humans; Methotrexate; Sirolimus; Tacrolimus; Transcriptome | 2015 |
Enteric-coated mycophenolate sodium containing GvHD prophylaxis reduces GvHD rate after allogeneic HSCT.
Topics: Adult; Aged; Drug Compounding; Drug Interactions; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Premedication; Proton Pump Inhibitors; Retrospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cohort Studies; Drug Substitution; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Transplantation Conditioning; Young Adult | 2016 |
Enteric-coated mycophenolate sodium could be an alternative to methotrexate for GVHD prophylaxis.
Topics: Drug Compounding; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Premedication | 2016 |
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Killer Cells, Natural; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pregnancy; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2016 |
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies; Siblings; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Reduced-dose methotrexate in combination with tacrolimus was associated with rapid engraftment and recovery from oral mucositis without affecting the incidence of GVHD.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Survival; Graft vs Host Disease; Humans; Incidence; Methotrexate; Stomatitis; Tacrolimus; Time Factors | 2016 |
Umbilical cord blood transplantation for adults using tacrolimus with two-day very-short-term methotrexate for graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Female; Graft Survival; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Neutrophils; Premedication; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Calcineurin Inhibitors; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, B-Cell; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
Topics: Adult; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Proportional Hazards Models; Recurrence; Survival Rate; Transplantation, Homologous | 2016 |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Topics: Adolescent; Adult; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Survival Rate; Tacrolimus | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mortality; Mycophenolic Acid; Neutrophils; Premedication; Retrospective Studies; Stem Cell Transplantation; Unrelated Donors; Young Adult | 2017 |
Is day +1 omission of methotrexate associated with higher incidence of acute GvHD in hematopoietic stem cell transplantation?
Topics: Acute Disease; Adolescent; Adult; Allografts; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Methotrexate; Middle Aged; Survival Rate; Time Factors | 2017 |
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
Topics: Aged; Calcineurin Inhibitors; Cohort Studies; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2017 |
Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Risk Factors; Treatment Outcome | 2008 |
The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Chronic Disease; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Methylenetetrahydrofolate Dehydrogenase (NAD+); Middle Aged; Polymorphism, Single Nucleotide; Time Factors; Transplantation, Homologous; Young Adult | 2008 |
Folinic acid administration following MTX as prophylaxis for GVHD in allogeneic HSCT centres in Australia and New Zealand.
Topics: Australia; Data Collection; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leucovorin; Male; Methotrexate; Mucositis; New Zealand; Transplantation, Homologous; Vitamin B Complex | 2008 |
Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mucositis; Mycophenolic Acid; Prospective Studies; Transplantation Conditioning; Young Adult | 2009 |
Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience.
Topics: Administration, Oral; Busulfan; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Lysosomal Storage Diseases; Male; Methotrexate; Peroxisomal Disorders; Vidarabine | 2008 |
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.
Topics: Adult; Aged; Boston; Calcineurin; Calcineurin Inhibitors; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphoma; Methotrexate; Middle Aged; Retrospective Studies; Sirolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2008 |
Outcome of bone marrow transplantation from HLA-identical sibling donor in children with hematological malignancies using methotrexate alone as prophylaxis for graft-versus-host disease.
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Child; Child, Preschool; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Incidence; Infant; Living Donors; Male; Methotrexate; Retrospective Studies; Risk Factors; Siblings; Survival Rate | 2008 |
Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus; Whole-Body Irradiation; Young Adult | 2008 |
Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2008 |
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Melphalan; Methotrexate; Middle Aged; Mycophenolic Acid; Premedication; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2009 |
Folinic acid administration following MTX as prophylaxis for GVHD.
Topics: Animals; Dogs; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate; Vitamin B Complex | 2009 |
Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Bone Marrow Transplantation; Chronic Disease; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Middle Aged; Mycophenolic Acid; Survival Rate; Tacrolimus; Transplantation Conditioning | 2009 |
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Incidence; Leukemia, Myeloid; Living Donors; Male; Methotrexate; Middle Aged; Prospective Studies; Survival Analysis; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphoma.
Topics: Calcineurin Inhibitors; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphoma; Methotrexate; Sirolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2009 |
Ocular findings after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Methotrexate; Middle Aged; Ophthalmoscopy; Retrospective Studies; Transplantation, Homologous; Visual Acuity | 2009 |
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis.
Topics: Adult; Aged; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Primary Myelofibrosis; Severity of Illness Index; Sirolimus; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2010 |
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Matched-Pair Analysis; Methotrexate; Survival Rate; Tacrolimus; Tissue Donors | 2009 |
Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome; Young Adult | 2009 |
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Siblings; Survival Rate; Transplantation, Homologous | 2010 |
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mucositis; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2010 |
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Thalassemia; Treatment Outcome; Young Adult | 2010 |
[Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Young Adult | 2010 |
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Topics: Adult; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Cyclosporine; Drug Resistance, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Methotrexate; Natural Killer T-Cells; Neoplasm Recurrence, Local; Nose Neoplasms; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
Topics: Administration, Oral; Alleles; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Capsules; Combined Modality Therapy; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dacarbazine; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Graft vs Host Disease; Half-Life; Hodgkin Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Intestines; Itraconazole; Methotrexate; Tacrolimus; Transplantation, Homologous; Vinblastine; Young Adult | 2010 |
Methotrexate Reduces the Incidence of Severe Acute Graft-versus-Host Disease without Increasing the Risk of Relapse after Reduced-Intensity Allogeneic Stem Cell Transplantation from Unrelated Donors.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Antimetabolites, Antineoplastic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Retrospective Studies; Secondary Prevention; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Dogs; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hyaluronan Receptors; Immunosuppressive Agents; Major Histocompatibility Complex; Methotrexate; Models, Animal; Mycophenolic Acid; Transplantation Conditioning | 2010 |
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Platelets; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Neutrophils; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2011 |
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Topics: Adult; Antilymphocyte Serum; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sirolimus; Survival Analysis; Tacrolimus; Thrombotic Microangiopathies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors.
Topics: Adrenal Cortex Hormones; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Dasatinib; Diphosphonates; Disease-Free Survival; Epoetin Alfa; Erythropoietin; Evidence-Based Medicine; Gemtuzumab; Graft vs Host Disease; Hematologic Neoplasms; Hodgkin Disease; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Randomized Controlled Trials as Topic; Recombinant Proteins; Rituximab; Stem Cell Transplantation; Thiazoles; Treatment Outcome; Vidarabine | 2011 |
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2011 |
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Standard of Care; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
Efficacy of folinic acid in preventing oral mucositis in allogeneic hematopoietic stem cell transplant patients receiving MTX as prophylaxis for GVHD.
Topics: Adolescent; Adult; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leucovorin; Male; Methotrexate; Middle Aged; Retrospective Studies; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2012 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in Japan: the impact of methotrexate on clinical outcomes.
Topics: Blood Platelets; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Female; Graft vs Host Disease; Humans; Infant, Newborn; Japan; Male; Methotrexate; Neutrophils; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Whole-Body Irradiation | 2011 |
Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Child; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Time Factors; Tissue Donors; Transplantation, Homologous | 2012 |
Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Opportunistic Infections; Quality of Life; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
Topics: Adult; Aged; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Recurrence; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.
Topics: Antineoplastic Agents; Australia; Cohort Studies; Disease-Free Survival; DNA Mutational Analysis; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Severity of Illness Index; Stomatitis; Transplantation, Homologous | 2012 |
Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Diabetes Mellitus, Type 2; Edema; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Insulin; Leg; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Skin Diseases; Tacrolimus; Treatment Outcome | 2012 |
Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Mucositis; Myelodysplastic Syndromes; Platelet Count; Statistics as Topic; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2011 |
Twice daily i.v. bolus tacrolimus infusion for GVHD prophylaxis in children undergoing stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Male; Methotrexate; Mycophenolic Acid; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Transplantation Conditioning | 2012 |
Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Folic Acid Antagonists; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leucovorin; Male; Methotrexate; Mucositis; Retrospective Studies; Severity of Illness Index; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Vitamin B Complex | 2013 |
Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Young Adult | 2013 |
ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chi-Square Distribution; Drug Interactions; Female; Genotype; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Models, Biological; Multidrug Resistance-Associated Protein 2; Penicillins; Phenotype; Polymorphism, Genetic; Prospective Studies; Republic of Korea; Treatment Outcome; Young Adult | 2012 |
Towards rational graft-versus-host disease prophylaxis.
Topics: Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Sirolimus; Tacrolimus | 2012 |
[Efficacy of allogeneic hematopoietic stem cell transplantation in treatment of childhood myelogenous leukemia: the observation of 24 cases].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2012 |
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Methotrexate; Mice; Mice, Inbred C57BL; Models, Animal; Mycophenolic Acid; Time Factors; Transplantation, Homologous | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
[Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2002 |
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, Viral; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Tacrolimus; Transplantation, Homologous | 2002 |
Omission of day +11 methotrexate after allogeneic bone marrow transplantation is associated with increased risk of severe acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Child; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Methotrexate; Recurrence; Retrospective Studies; Risk; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2002 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; DNA, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-A Antigens; HLA-B Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Infant; Living Donors; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Registries; Remission Induction; Survival Rate; Time Factors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2002 |
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Topics: ABO Blood-Group System; Adolescent; Adult; Aged; Anemia, Hemolytic; B-Lymphocytes; Blood Group Incompatibility; Carcinoma, Renal Cell; Erythrocyte Transfusion; Female; Graft vs Host Disease; Hematologic Neoplasms; Hemolysis; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Peripheral Blood Stem Cell Transplantation; Prevalence; Rh-Hr Blood-Group System; Survival Analysis; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neutrophils; Survival Rate; Thalassemia; Transplantation, Homologous; Treatment Outcome | 2003 |
Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Catheters, Indwelling; Child; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Liver Diseases; Male; Methotrexate; Methylprednisolone; Middle Aged; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2002 |
Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia.
Topics: Adolescent; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Humans; Immune Tolerance; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Nuclear Family; Tacrolimus; Transplantation Chimera; Treatment Outcome | 2002 |
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Cell Lineage; Child; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haplotypes; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Lenograstim; Leukemia; Life Tables; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Risk Factors; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2002 |
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Chronic Disease; Disease-Free Survival; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2002 |
Psychological factors and survival after bone marrow transplantation in patients with leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Mood Disorders; Sex Distribution | 2003 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Topics: Aged; Bone Marrow Transplantation; Busulfan; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Intestines; Life Tables; Liver; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Severity of Illness Index; Skin; Survival Analysis; Time Factors; Tissue Donors; Transplantation Conditioning; Vidarabine; Washington; Whole-Body Irradiation | 2003 |
[Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin.
Topics: Adult; Antineoplastic Agents; Benzamides; Family; Female; Genes, abl; Graft vs Host Disease; Haplotypes; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Biphenotypic, Acute; Methotrexate; Methylprednisolone; Mycophenolic Acid; Pedigree; Piperazines; Pyrimidines; Tacrolimus; Tissue Donors; Transplantation, Homologous | 2003 |
Allogeneic PBPC transplantation in children.
Topics: Adolescent; Anemia; Antigens, CD34; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Stem Cells; Transplantation, Homologous | 1999 |
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Aged; Cyclosporine; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Psoriasis; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
THE TREATMENT OF CHRONIC MURINE HOMOLOGOUS DISEASE: A COMPARATIVE STUDY OF FOUR "IMMUNOSUPPRESSIVE" AGENTS.
Topics: Animals; Antigens; Cachexia; Graft vs Host Disease; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mice; Pharmacology; Prednisone; Radiation Effects; Research; Spleen; Transplantation Immunology | 1965 |
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Topics: Adult; Bone Marrow Diseases; Bone Marrow Transplantation; Brain; Calcineurin Inhibitors; Central Nervous System Diseases; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2003 |
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD34; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leucovorin; Leukemia, Myeloid; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine | 2003 |
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence | 2004 |
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Population Surveillance; Postoperative Care; Retrospective Studies; Risk Assessment; Severity of Illness Index; Siblings; Stem Cell Transplantation | 2004 |
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.
Topics: Adult; Blood Cells; Bone Marrow Transplantation; Chronic Disease; Cohort Studies; Cyclosporine; Drug Therapy, Combination; fas Receptor; Female; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interleukins; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2004 |
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Vidarabine | 2004 |
Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
Topics: Acute Disease; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Bone Marrow Transplantation; Drug Therapy, Combination; Enzyme Inhibitors; Graft vs Host Disease; Immunosuppressive Agents; Janus Kinase 3; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitriles; Protein-Tyrosine Kinases; Quinazolines; Survival Rate; Treatment Outcome | 2004 |
Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells.
Topics: Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes; Cell Differentiation; Cytotoxicity, Immunologic; Fluorouracil; Graft vs Host Disease; Immunization; Immunologic Memory; Interferon-gamma; Methotrexate; Mice; Mice, Inbred C57BL; Mycophenolic Acid; Nucleotides | 2004 |
[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2004 |
Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; T-Lymphocytes; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning | 2005 |
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; CD3 Complex; Child; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Recurrence; Risk; Stem Cell Transplantation; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Neutrophils; Time Factors; Transfusion Reaction; Transplantation, Homologous; Treatment Outcome | 2005 |
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Topics: Adult; Cohort Studies; Drug Evaluation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Male; Methotrexate; Middle Aged; Mouth Mucosa; Premedication; Retrospective Studies; Sirolimus; Stomatitis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2005 |
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Immunophenotyping; Infant; Male; Methotrexate; Odds Ratio; Regression Analysis; Reoperation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation.
Topics: Adenoviridae Infections; Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Methotrexate; Myelodysplastic Syndromes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Rejection; Graft vs Host Disease; Hematologic Diseases; Humans; Infant; Japan; Male; Methotrexate; Methylprednisolone; Premedication; Retrospective Studies; Tacrolimus; Tissue Donors | 2005 |
Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease.
Topics: Adult; Aged; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2005 |
[Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Child; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Stem Cell Transplantation | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Male; Methotrexate; Middle Aged; Multivariate Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis.
Topics: ABO Blood-Group System; Adult; B-Lymphocytes; Benzamides; Blood Group Incompatibility; Graft vs Host Disease; Hemolysis; Humans; Imatinib Mesylate; Immunosuppressive Agents; Male; Methotrexate; Piperazines; Pyrimidines; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Edema; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2005 |
Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens.
Topics: Adult; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Mucositis; Mycophenolic Acid; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antigens, CD34; Cell Count; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2006 |
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Topics: Adult; Bone Marrow; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2006 |
Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Dietary Supplements; Female; Folic Acid; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
Topics: Adolescent; Adult; Aged; Cohort Studies; DNA; Female; Folic Acid; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Models, Statistical; Multivariate Analysis; Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Proportional Hazards Models; Stem Cell Transplantation; Stem Cells; Time Factors; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Cyclosporine; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Recombinant Proteins; Remission Induction; Transplantation, Homologous | 2006 |
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Fibrosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Myeloablative Agonists; Scleroderma, Systemic; Skin; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infe
Topics: Acute Disease; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Isogeneic; Treatment Outcome; Virus Diseases | 2006 |
Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Family; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine | 2006 |
Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model.
Topics: Animals; Antineoplastic Agents; Diphtheria Toxin; Dogs; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesviridae Infections; Immunosuppressive Agents; Interleukin-2; Methotrexate; Models, Animal; Recombinant Fusion Proteins; Time Factors; Whole-Body Irradiation | 2006 |
Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
Topics: Acute Disease; Aminopterin; Animals; Female; Graft vs Host Disease; Immunosuppressive Agents; Leukocytes, Mononuclear; Methotrexate; Rats; Rats, Inbred Lew; Serum Albumin | 2006 |
[Clinical study of unrelated umbilical cord blood transplantation in 32 children patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Survival Rate; Transplantation Conditioning | 2006 |
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adult; Drug Administration Schedule; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Topics: Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Rabbits; Transplantation, Homologous | 2006 |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Topics: Adolescent; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Retrospective Studies; Siblings; Survival Analysis; T-Lymphocyte Subsets; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation.
Topics: Antigens, CD34; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Methotrexate; Prognosis; Randomized Controlled Trials as Topic | 2007 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia/lymphoma.
Topics: Female; Fetal Blood; Graft vs Host Disease; Humans; Leukemia, T-Cell; Lymphoma, T-Cell; Methotrexate; Middle Aged; Skin Neoplasms; Stem Cell Transplantation; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2007 |
Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chimerism; Drug Therapy, Combination; Genetic Diseases, Inborn; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2007 |
Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Cochlear Implantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Time Factors; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
In vitro methotrexate as a practical approach to selective allodepletion.
Topics: Antigens, Viral; Cell Proliferation; Cells, Cultured; Graft vs Host Disease; Histocompatibility Testing; Humans; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Methods; Methotrexate; T-Lymphocytes; Transplantation, Homologous | 2007 |
Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Probability; Tacrolimus; Transplantation Conditioning | 2007 |
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prednisolone; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2007 |
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Premedication; Retrospective Studies; Risk Factors | 2007 |
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone; Retrospective Studies; Time Factors; Treatment Outcome | 2008 |
Atypical acute graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Erythema; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Treatment Outcome | 2007 |
Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome | 2007 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Topics: Acute Disease; Adolescent; beta-Thalassemia; Blood Platelets; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Recovery of Function; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2008 |
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Donors | 2008 |
Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.
Topics: Acute Disease; Adolescent; Adult; Female; Genotype; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Transplantation, Homologous | 2008 |
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Topics: Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Tacrolimus | 2008 |
Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporins; Cytomegalovirus Infections; Female; Gaucher Disease; Graft vs Host Disease; Humans; Male; Methotrexate; Neoplasms | 1984 |
[Immunologic problems in allogenic and autologous bone marrow transplantation].
Topics: Antigens, Viral; B-Lymphocytes; Bone Marrow Transplantation; Graft Rejection; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immune Tolerance; Immunocompetence; Immunoglobulins; Leukemia; Methotrexate; Pokeweed Mitogens; Recurrence; T-Lymphocytes; Transfer Factor; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous | 1984 |
Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease.
Topics: Antibodies, Viral; Antibody Formation; Bacteriophage phi X 174; Bone Marrow Transplantation; Complement System Proteins; Cyclosporins; Graft vs Host Disease; Hemocyanins; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leukocyte Count; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methotrexate; Phytohemagglutinins; Skin Tests | 1984 |
Fractionated total body irradiation in marrow transplantation for leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Pulmonary Fibrosis; Radiotherapy Dosage; Whole-Body Irradiation | 1983 |
Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Cyclophosphamide; Facial Expression; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Penicillamine; Skin Diseases | 1983 |
Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates.
Topics: Animals; Bone Marrow Transplantation; Cyclosporins; Dogs; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunosuppression Therapy; Methotrexate | 1984 |
Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimeras.
Topics: Animals; Blood Transfusion; Dogs; Female; Freezing; Graft vs Host Disease; Leukocytes; Male; Methotrexate; Preservation, Biological; Radiation Chimera; Sex Chromosomes; Whole-Body Irradiation | 1984 |
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Infant; Leukemia; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Sex Factors; Transplantation, Homologous; Whole-Body Irradiation | 1984 |
Immunological monitoring of bone marrow transplant recipients. I. Major leucocyte subclasses in the blood.
Topics: Adult; Bone Marrow Transplantation; Concanavalin A; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Lymphocyte Activation; Lymphocytes; Male; Methotrexate; Methylprednisolone; Phytohemagglutinins | 1984 |
Parenteral nutrition in marrow transplant recipients after discharge from the hospital.
Topics: Adolescent; Adult; Age Factors; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Evaluation Studies as Topic; Failure to Thrive; Female; Graft vs Host Disease; Home Nursing; Humans; Interferon Type I; Leukemia; Male; Methotrexate; Middle Aged; Parenteral Nutrition; Stomatitis | 1983 |
Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell products.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Prednisone; Thioguanine; Transfusion Reaction; Vincristine | 1983 |
Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.
Topics: Antibody-Dependent Cell Cytotoxicity; Bone Marrow Transplantation; Cell Line; Graft vs Host Disease; Humans; Killer Cells, Natural; L Cells; Mathematics; Methotrexate; Time Factors | 1981 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1995 |
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Lymphocyte Depletion; Lymphocytosis; Male; Methotrexate; Middle Aged; Pneumonia, Viral; T-Lymphocytes; Transplantation, Homologous | 1995 |
Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged | 1995 |
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis | 1995 |
Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts.
Topics: Animals; Bone Marrow Transplantation; Corticotropin-Releasing Hormone; Dogs; Graft Survival; Graft vs Host Disease; Methotrexate | 1995 |
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Leukemia, Myeloid, Acute; Methotrexate; Neutropenia; Prednisolone | 1993 |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
Topics: Animals; Bone Marrow Transplantation; Dogs; Graft Survival; Graft vs Host Disease; Granulocytes; Histocompatibility Testing; Methotrexate; Tacrolimus; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Survival Analysis | 1994 |
Total body irradiation: a neuropsychological risk factor in pediatric bone marrow transplant recipients.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Injections, Spinal; Leukemia; Male; Mental Disorders; Methotrexate; Nervous System Diseases; Neuropsychological Tests; Radiation Dosage; Risk Factors; Time Factors; Whole-Body Irradiation | 1995 |
Reusable influence diagrams.
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Bayes Theorem; Bone Marrow Transplantation; Child; Cyclosporine; Decision Support Techniques; Expert Systems; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Models, Biological; Neural Networks, Computer; Patient Care Planning; Prognosis; Sex Factors; Systems Integration | 1994 |
Bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Lymphatic Irradiation; Male; Methotrexate; Survival Rate | 1993 |
Bone marrow transplantation in Hong Kong.
Topics: Bone Marrow Transplantation; Cyclosporine; Family Health; Graft vs Host Disease; Histocompatibility; Hong Kong; Humans; Methotrexate; Middle Aged; National Health Programs; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1994 |
Bone marrow transplantation for primary refractory acute leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Survival Rate | 1994 |
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility Testing; Humans; Infant; Leukemia; Lymphocyte Depletion; Methotrexate; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Transplantation, Homologous | 1994 |
Prevention of graft-versus-host disease on an individual basis.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Methotrexate; Retrospective Studies; Risk Factors | 1994 |
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Bone Marrow Transplantation; CD52 Antigen; Complement System Proteins; Cyclosporine; Female; Glycoproteins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; T-Lymphocytes | 1994 |
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Bone marrow transplantation in Thailand.
Topics: Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Fetal Blood; Graft vs Host Disease; Histocompatibility Testing; Humans; Incidence; Leukemia; Methotrexate; Thailand; Thalassemia; Transplantation, Homologous | 1994 |
Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Creatinine; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Humans; Infusion Pumps; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Postoperative Care; Transplantation, Homologous | 1994 |
[Relapse of acute leukemia after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate | 1994 |
Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Humans; Incidence; Methotrexate; Prednisone; Prospective Studies; PUVA Therapy; Retrospective Studies; Severity of Illness Index; Stem Cells; T-Lymphocytes, Cytotoxic; Tissue Donors | 1994 |
Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chromatography, High Pressure Liquid; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Retrospective Studies; Time Factors | 1994 |
Cold agglutinin disease following allogeneic bone marrow transplantation.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Incidence; Male; Methotrexate; Prednisolone; Transplantation, Homologous | 1994 |
Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cataract; Cataract Extraction; Child; Child, Preschool; Cohort Studies; Graft vs Host Disease; Humans; Incidence; Life Tables; Lymphocyte Depletion; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Radiation Injuries; Risk; Whole-Body Irradiation | 1993 |
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors | 1993 |
Marrow transplant experience for children with severe aplastic anemia.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Graft Rejection; Graft vs Host Disease; Growth; Humans; Methotrexate; Survival Rate; Transplantation, Isogeneic | 1994 |
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Retrospective Studies | 1993 |
Role of natural killer cells in the pathogenesis of human acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD; B-Lymphocyte Subsets; Bone Marrow Transplantation; CD3 Complex; Child; Flow Cytometry; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunophenotyping; Killer Cells, Natural; Methotrexate; Middle Aged; Receptors, IgG; Skin; T-Lymphocyte Subsets | 1993 |
Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Graft vs Host Disease; Histiocytoma, Benign Fibrous; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Radiography | 1993 |
Rate of marrow engraftment does not appear to be adversely affected by early marrow infusion after total body irradiation.
Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Topics: Alleles; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Leukemia; Methotrexate; Transplantation, Homologous | 1993 |
Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Infant; Italy; Leukemia; Methotrexate; Middle Aged; Tissue Donors; Transplantation, Homologous | 1993 |
Folinic acid rescue after methotrexate.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Leucovorin; Methotrexate | 1993 |
Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Risk Factors | 1993 |
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility; Humans; Leukemia; Male; Methotrexate; Middle Aged; Recombinant Proteins; Recurrence; Survival Rate; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1995 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Allogeneic bone marrow transplatation in a patient with Shwachman-Diamond syndrome.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Exocrine Pancreatic Insufficiency; Fatal Outcome; Female; Graft vs Host Disease; Humans; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Pregnancy; Syndrome | 1996 |
Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Topics: beta-Thalassemia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cells, Cultured; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Hemoglobin E; Hemoglobinuria; Homozygote; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Reference Values | 1995 |
High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Down Syndrome; Fatal Outcome; Graft vs Host Disease; Humans; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Salvage Therapy; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1996 |
Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Cytokines; Etoposide; Gene Expression; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Interleukins; Lymphocytes; Methotrexate; Polymerase Chain Reaction; RNA, Messenger; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation | 1996 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Dogs; Drug Synergism; Graft Rejection; Graft vs Host Disease; Histocompatibility; Histocompatibility Antigens; Immunosuppressive Agents; Intussusception; Methotrexate; Radiation Chimera; Tacrolimus; Transplantation Conditioning | 1996 |
A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Neoplasms; Risk Factors; Transplantation Conditioning; Whole-Body Irradiation | 1996 |
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow; Catheterization, Central Venous; Child; Cyclosporine; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lenograstim; Leukapheresis; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Recombinant Proteins; Retreatment; Retrospective Studies; Safety; Transplantation, Homologous; Treatment Outcome | 1996 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantatio
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia; Methotrexate; Middle Aged; Recurrence; Transplantation, Homologous; Treatment Outcome | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Clinical Protocols; Cyclosporine; Europe; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Surveys and Questionnaires; Transplantation, Homologous | 1997 |
Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation.
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Injections, Spinal; Killer Cells, Natural; Male; Methotrexate; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 1997 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prognosis; Recurrence; Renal Insufficiency; Tacrolimus; Transplantation, Homologous | 1997 |
Very low-dose methotrexate in the treatment of GVHD in children.
Topics: Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Transplantation, Homologous | 1997 |
Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Dogs; Drug Synergism; Drug Therapy, Combination; Glucocorticoids; Graft vs Host Disease; Histocompatibility Antigens Class I; Immunosuppressive Agents; Methotrexate; Tacrolimus | 1997 |
Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow Transplantation; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Retrospective Studies; Statistics, Nonparametric; Transplantation, Homologous | 1997 |
Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Purging; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoid Tissue; Male; Methotrexate; Middle Aged; Risk Factors; Survival Rate; Transplantation Conditioning | 1996 |
Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE).
Topics: 2-Aminoadipic Acid; Age Factors; Animals; Autoantibodies; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Disease Models, Animal; Female; Folic Acid Antagonists; Graft vs Host Disease; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Mice; Mice, Inbred DBA; Mice, Inbred NZB; Proteinuria | 1997 |
Linear chronic cutaneous graft-versus-host disease.
Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Topics: Abdominal Pain; Acute Disease; Adult; Amylases; Bile; Biomarkers; Bone Marrow Transplantation; Cause of Death; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Gallbladder; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Neoplasms; Pancreatitis; Prednisone; Prevalence; Risk Factors; Transplantation Conditioning; Whole-Body Irradiation | 1997 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 1998 |
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mass Screening; Methotrexate; Multivariate Analysis; Risk Factors; Transplantation, Homologous | 1998 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation, Homologous; Treatment Outcome | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infections; Life Tables; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Survival Rate; Transplantation, Homologous | 1998 |
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Transplantation, Homologous | 1998 |
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Transplantation of allogeneic peripheral blood progenitor cells--a single centre experience.
Topics: Adult; Cyclosporine; Czech Republic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Topics: Adolescent; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Female; Finland; Graft vs Host Disease; Humans; Iceland; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome | 1999 |
Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Diagnosis, Differential; Diarrhea; Fatal Outcome; Fever; Graft vs Host Disease; Humans; Liver Failure; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Renal Insufficiency; Stevens-Johnson Syndrome | 1999 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
[T cell non-depleted bone marrow transplantation for primary refractory erythroleukemia using a partially HLA-mismatched related donor].
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Erythroblastic, Acute; Male; Methotrexate; Middle Aged; Remission Induction; T-Lymphocytes; Tacrolimus; Tissue Donors | 1999 |
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multiple Myeloma; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Alleles; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; HLA-A2 Antigen; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Middle Aged; Minor Histocompatibility Antigens; Nuclear Family; Oligopeptides; Parity; Retrospective Studies; Risk; Severity of Illness Index; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Tacrolimus | 1999 |
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Bone Marrow Transplantation; CTLA-4 Antigen; Cyclosporine; Dogs; Graft vs Host Disease; Histocompatibility Testing; Immunoconjugates; Immunoglobulin Fc Fragments; Immunosuppressive Agents; Methotrexate; Recombinant Fusion Proteins; Transplantation Immunology; Transplantation, Homologous | 2000 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Topics: Acute Disease; Adolescent; Adult; Alleles; Bone Marrow Transplantation; Female; Filgrastim; Genes, MHC Class II; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Histocompatibility; HLA-DQ Antigens; HLA-DR Antigens; Humans; Male; Methotrexate; Middle Aged; Recombinant Proteins; Risk Factors; Survival Rate; Tacrolimus; Tissue Donors; Treatment Outcome | 2000 |
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Child; Child, Preschool; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infections; Liver Failure; Magnesium Deficiency; Male; Methotrexate; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Vascular Diseases | 2000 |
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.
Topics: Adolescent; Adrenal Cortex Hormones; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Data Collection; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Infant, Newborn; International Agencies; Lymphocyte Depletion; Methotrexate; Practice Guidelines as Topic; T-Lymphocytes; Transplantation, Homologous | 2000 |
The problem of thrombocytopenia after hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk; Risk Factors; Sex Factors; Thrombocytopenia; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 1996 |
Radiation recall dermatitis induced by methotrexate in a patient with Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Eruptions; Female; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Methotrexate; Radiodermatitis | 2000 |
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous | 2000 |
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Cyclosporine; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Prednisone; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice.
Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Transplantation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Enzyme Inhibitors; Graft vs Host Disease; H-2 Antigens; Immunosuppressive Agents; Janus Kinase 3; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Phytohemagglutinins; Protein-Tyrosine Kinases; Quinazolines; Radiation Chimera; Signal Transduction; Spleen; T-Lymphocytes, Cytotoxic; Whole-Body Irradiation | 2001 |
Atypical retinal microvasculopathy after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclophosphamide; Fluorescein Angiography; Graft vs Host Disease; Humans; Immunosuppressive Agents; Laser Coagulation; Leukemia; Male; Methotrexate; Middle Aged; Retinal Diseases; Retinal Vessels; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Topics: Adolescent; Adult; Cause of Death; Child; Child, Preschool; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Odds Ratio; Prednisone; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2001 |
Severe oral manifestations of chronic graft-vs.-host disease.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Betamethasone; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Methotrexate; Mouth Diseases; Mouthwashes; Mycophenolic Acid; Oral Hygiene; Prednisone; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Attribution of posttransplantation toxicity to methotrexate regarding genotype of methylenetetrahydrofolate reductase gene (MTHFR) polymorphism needs further clarification.
Topics: Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Mouth Mucosa; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Stomatitis | 2001 |
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Bone Marrow; Busulfan; Cell Count; Chromosomes, Human, Pair 7; Cyclophosphamide; Disease-Free Survival; Feasibility Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Karyotyping; Methotrexate; Middle Aged; Monosomy; Myelodysplastic Syndromes; Recurrence; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell transplantation: a little methotrexate goes a long way.
Topics: Disease-Free Survival; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Transplantation, Homologous | 2002 |
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Isogeneic; Treatment Outcome | 2002 |
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immune Tolerance; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Nuclear Family; Time Factors; Tissue Donors; Transplantation Chimera; Transplantation, Homologous | 2002 |
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Topics: Adult; Age Factors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Graft Rejection; Graft vs Host Disease; Graft vs Host Reaction; Humans; Immunosuppression Therapy; Methotrexate; Middle Aged; Platelet Transfusion; Sex Factors; Transplantation, Homologous; X-Rays | 1978 |
Immunodeficiency following human marrow transplantation: in vitro studies.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Lectins; Lymphocyte Activation; Methotrexate; Transplantation, Homologous | 1978 |
Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
Topics: Adult; Animals; Bone Marrow Transplantation; Cell Separation; Disease Models, Animal; Graft vs Host Disease; Haplorhini; Humans; Immunosuppression Therapy; Leukemia; Lymphocytes; Methotrexate; Middle Aged; Pulmonary Fibrosis; Transplantation, Autologous; Transplantation, Homologous | 1978 |
Allogeneic bone marrow transplantation: the Huddinge experience.
Topics: Adult; Anemia; Bone Marrow Transplantation; Candidiasis; Child; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia; Male; Methotrexate; Neoplasms; Retrospective Studies; Risk Factors; Sweden; Transplantation, Homologous | 1992 |
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antigens, Viral; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Depletion; Male; Methotrexate; Simplexvirus | 1992 |
Prevention and therapy of graft-versus-host disease. Report from a work-shop.
Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft vs Host Disease; Humans; Lymphocyte Depletion; Methotrexate; T-Lymphocytes | 1992 |
[Bone marrow transplantation for therapy of leukemia].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Leukemia; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Survival Rate | 1992 |
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic | 1992 |
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Leukemia; Lymphoma; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation | 1992 |
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.
Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Bone Marrow Transplantation; Child; Cyclosporine; Family; Female; Graft vs Host Disease; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Tissue Donors | 1992 |
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Topics: Animals; Bone Marrow Transplantation; Dogs; Drug Therapy, Combination; Graft Survival; Graft vs Host Disease; Haploidy; Heptanoates; Methotrexate | 1992 |
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Topics: Acute Disease; Adolescent; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Candidiasis, Oral; Chi-Square Distribution; Cyclosporine; Facial Pain; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nutritional Status; Oral Hemorrhage; Random Allocation; Stomatitis, Herpetic | 1992 |
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bilirubin; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Pilot Projects; Time Factors | 1992 |
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; HLA Antigens; Humans; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Survival Rate | 1992 |
Marrow transplantation in patients with acute myeloid leukemia.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Drug Administration Schedule; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Pentoxifylline; Radiotherapy Dosage; Recurrence; Remission Induction; Transplantation, Autologous; Whole-Body Irradiation | 1992 |
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Blood Cell Count; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leucovorin; Liver; Male; Methotrexate; Middle Aged; Mouth Mucosa; Neutrophils; Prospective Studies; Salvage Therapy; Transplantation, Homologous | 1992 |
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infant; Male; Methotrexate; Whole-Body Irradiation | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous | 1991 |
Small bowel transplantation in the rat: impact of various immunosuppressive regimens on graft-versus-host reaction.
Topics: Animals; Cyclosporins; Graft vs Host Disease; Graft vs Host Reaction; Immunosuppression Therapy; Intestine, Small; Leukocyte Count; Lymphocytes; Methotrexate; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1991 |
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporins; Graft vs Host Disease; Humans; Methotrexate | 1991 |
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Female; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Incidence; Male; Methotrexate; Middle Aged; Multivariate Analysis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 1991 |
Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.
Topics: Abdomen; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Middle Aged; Multivariate Analysis; Thorax | 1991 |
Deoxyspergualin in lethal murine graft-versus-host disease.
Topics: Animals; Antigens, Surface; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Guanidines; Histocompatibility Testing; Immunosuppressive Agents; Killer Cells, Natural; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred Strains; Spleen; T-Lymphocytes, Cytotoxic | 1991 |
Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
Topics: Administration, Oral; Animals; Bone Marrow Transplantation; Cyclosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Injections, Intraperitoneal; Methotrexate; Prednisolone; Rats; Rats, Inbred Lew; Whole-Body Irradiation | 1991 |
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporins; Glucocorticoids; Graft vs Host Disease; Humans; Intestinal Diseases; Liver Diseases; Methotrexate; Multivariate Analysis; Retrospective Studies; Skin Diseases | 1990 |
Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporins; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Infant; Lymphatic Irradiation; Male; Methotrexate | 1990 |
Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Drug Combinations; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prognosis; Recurrence; Transplantation, Homologous | 1990 |
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease.
Topics: Adolescent; Adult; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged | 1990 |
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Topics: Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporins; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Methotrexate; Prognosis | 1990 |
Acute lymphoblastic leukemia; factors influencing relapse after allogeneic bone marrow transplantation.
Topics: Adolescent; Bone Marrow Transplantation; Combined Modality Therapy; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 1990 |
Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Transplantation, Homologous | 1990 |
Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Colony-Stimulating Factors; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Infant; Leukocytes; Male; Methotrexate; Middle Aged; Recombinant Proteins; Recurrence | 1989 |
The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Candidiasis, Oral; Child; Child, Preschool; Cyclosporins; Female; Graft vs Host Disease; Herpes Simplex; Humans; Infant; Male; Methotrexate; Middle Aged; Mouth Diseases; Sepsis | 1989 |
Marrow transplantation from unrelated HLA-matched volunteer donors.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Methotrexate; Postoperative Complications; Tissue Donors; Volition | 1989 |
Combination prophylactic immunosuppression in bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Postoperative Complications | 1989 |
Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anaemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Postoperative Complications; Pulmonary Fibrosis; Radiotherapy; Risk Factors | 1989 |
Factors affecting survival in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Middle Aged; Postoperative Complications; Pulmonary Fibrosis; Recurrence; Reoperation | 1989 |
Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporins; Cytarabine; Erythema; Female; Foot Dermatoses; Graft vs Host Disease; Hand Dermatoses; Humans; Infusions, Intravenous; Male; Methotrexate; Pain; Pharmaceutical Vehicles; Whole-Body Irradiation | 1989 |
[Prevention of acute graft versus host disease using 3 prophylactic schemes].
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Drug Evaluation; Drug Therapy, Combination; Female; Graft Rejection; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Prednisone; Sex Factors; T-Lymphocytes; Transplantation Immunology | 1989 |
Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity.
Topics: Acute Disease; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporins; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia; Methotrexate; Multivariate Analysis | 1989 |
Marrow transplantation for thalassaemia following busulphan and cyclophosphamide.
Topics: Actuarial Analysis; Age Factors; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Infant; Male; Methotrexate; Thalassemia | 1985 |
Bone marrow transplantation as treatment of hematologic disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Combined Modality Therapy; Female; Graft vs Host Disease; Hematologic Diseases; HLA Antigens; Humans; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphocyte Culture Test, Mixed; Methotrexate; Tissue Donors; Whole-Body Irradiation | 1986 |
Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
Topics: Animals; Bone Marrow Transplantation; Cyclosporins; Cytotoxicity, Immunologic; Dogs; Female; Graft vs Host Disease; Haploidy; Histocompatibility Antigens; Histocompatibility Antigens Class I; Immune Tolerance; Immunocompetence; Leukocyte Transfusion; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methotrexate; Radiation Chimera; Transplantation, Homologous; Whole-Body Irradiation | 1987 |
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Viral; Bone Marrow Transplantation; Child; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infections; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Graft vs Host Disease; Humans; Immunoglobulin G; Immunoglobulin M; Leukemia; Leukocyte Count; Male; Methotrexate; T-Lymphocytes | 1985 |
Bone-marrow transplantation for haematological malignancy in childhood.
Topics: Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Evaluation Studies as Topic; Female; Graft vs Host Disease; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Lymphatic Diseases; Male; Methotrexate; Pneumonia; Premedication; Prognosis; Recurrence; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1986 |
Allogeneic bone marrow transplantation in children: Tokai experience 1982 to 1984.
Topics: Acute Disease; Acyclovir; Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Male; Methotrexate; Transplantation, Homologous | 1985 |
Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: a preliminary report.
Topics: Aging; Anemia, Aplastic; Bone Marrow Transplantation; Combined Modality Therapy; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Prognosis; Pulmonary Fibrosis; Registries; Risk; Whole-Body Irradiation | 1987 |
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemia.
Topics: Acute Disease; Adult; Bone Marrow; Bone Marrow Transplantation; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Recurrence; T-Lymphocytes | 1988 |
Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Child; Cyclosporins; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Lymphocyte Depletion; Methotrexate; T-Lymphocytes, Cytotoxic | 1988 |
Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Infant; Lymphocyte Culture Test, Mixed; Male; Methotrexate; Prednisone; Tissue Donors | 1985 |
A comparative trial of posttransplant immunosuppression in patients transplanted for thalassemia. Cyclosporine alone versus cyclosporine, cyclophosphamide, and methotrexate.
Topics: Adolescent; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Postoperative Period; Thalassemia; Transplantation, Homologous | 1988 |
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Risk Factors | 1988 |
Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Administration, Oral; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Infusions, Intravenous; Methotrexate; Time Factors | 1988 |
Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Graft Survival; Graft vs Host Disease; HLA Antigens; Humans; Methotrexate; Mouth Diseases; Opportunistic Infections; Sepsis | 1988 |
[Allogeneic bone marrow transplantation in 91 patients with acute leukemia (Nagoya Bone Marrow Transplantation Group)].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Remission Induction; Transplantation, Homologous | 1988 |
[Allogenic bone marrow grafts in chronic myeloid leukemia].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Premedication; Splenectomy | 1987 |
[Bone marrow transplantation after intensive chemotherapy].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myeloid; Male; Methotrexate; Whole-Body Irradiation | 1987 |
Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation.
Topics: Antigens, Surface; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclophosphamide; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Methotrexate; Philadelphia Chromosome; Prednisone; Probability; T-Lymphocytes; Time Factors; Whole-Body Irradiation | 1987 |
Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Dogs; Graft Survival; Graft vs Host Disease; Histocompatibility Antigens; Histocompatibility Antigens Class II; Isoantibodies; Methotrexate; Whole-Body Irradiation | 1987 |
Risk factors for airflow obstruction in recipients of bone marrow transplants.
Topics: Adult; Analysis of Variance; Bone Marrow Transplantation; Chronic Disease; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Lung Diseases, Obstructive; Male; Methotrexate; Postoperative Complications; Risk Factors; Vital Capacity | 1987 |
Clonogenic hemopoietic precursors in bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Cells, Cultured; Clone Cells; Colony-Forming Units Assay; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Transplantation, Homologous | 1987 |
Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
Topics: Bone Marrow; Bone Marrow Transplantation; Cell Separation; Cyclosporins; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; T-Lymphocytes | 1987 |
HLA-mismatched allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; HLA-D Antigens; Humans; Leukemia, Myeloid, Acute; Methotrexate; Remission Induction; Transplantation, Homologous | 1987 |
Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
Topics: Cyclosporins; Drug Therapy, Combination; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Methotrexate; Preoperative Care; Sweden | 1988 |
Acute and chronic graft-versus-host disease: clinical manifestations, prophylaxis, and treatment.
Topics: Acute Disease; Age Factors; Animals; Chronic Disease; Cyclosporins; Dogs; Glucocorticoids; Graft vs Host Disease; Humans; Infections; Intestinal Diseases; Liver Diseases; Methotrexate; Risk; Skin Diseases | 1986 |
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Graft vs Host Disease; Humans; Infant; Leukemia; Male; Methotrexate; Middle Aged; Postoperative Complications; Pulmonary Fibrosis; Radiation Injuries; Risk; Time Factors; Whole-Body Irradiation | 1986 |
Influence of graft-versus-host disease prophylaxis on early T-lymphocyte regeneration following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporins; Female; Graft vs Host Disease; Humans; Leukocyte Count; Male; Methotrexate; T-Lymphocytes; Time Factors | 1986 |
Natural killer cell activity against a thymoma cell line Thy 121 in bone marrow transplant recipients.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cell Line; Child; Cyclosporins; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Interferon Type I; Killer Cells, Natural; Leukemia; Methotrexate; Postoperative Complications; Risk; Thymoma | 1986 |
Modified methotrexate regimen for prevention of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Drug Administration Schedule; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Time Factors | 1986 |
Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cell Separation; Cell Survival; Centrifugation; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Lymphocytes; Male; Methotrexate; Transplantation, Homologous | 1986 |
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation--combination protocol of high dose methylprednisolone, prednisolone and methotrexate].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child, Preschool; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Methylprednisolone; Prednisolone; Transplantation, Homologous | 1986 |
Allogeneic bone marrow transplantation at Christchurch 1979-1985.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Premedication; Retrospective Studies; Transplantation, Homologous | 1986 |
Oral complications of bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Middle Aged; Mouth Diseases; Mouth Mucosa; Prospective Studies; Sialadenitis; Whole-Body Irradiation | 1986 |
Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.
Topics: Blood Grouping and Crossmatching; Blood Platelets; Bone Marrow Cells; Bone Marrow Transplantation; Colony-Forming Units Assay; Graft vs Host Disease; Hematopoietic Stem Cells; HLA Antigens; Humans; Methotrexate | 1987 |
Neurologic complications of bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Brain Diseases, Metabolic; Central Nervous System; Central Nervous System Diseases; Cerebrovascular Disorders; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Infections; Leukemia; Male; Methotrexate; Middle Aged; Necrosis; Neoplasms; Postoperative Complications; Seizures; Spinal Cord Diseases | 1985 |
Efficacy of a short course (four doses) of methotrexate following bone marrow transplantation for prevention of graft-versus-host disease.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Postoperative Complications; Pulmonary Fibrosis | 1985 |
Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Female; Graft vs Host Disease; Hirsutism; Humans; Kidney; Leukemia; Liver; Lung Diseases; Male; Methotrexate; Nausea; Tremor; Vomiting | 1985 |
Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Middle Aged; Prednisone; T-Lymphocytes | 1985 |
Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Female; Graft vs Host Disease; Humans; Leukemia, Lymphoid; Male; Methotrexate; Recurrence; Whole-Body Irradiation | 1985 |
Serum immunoglobulin levels following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graft vs Host Disease; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Infant; Male; Methotrexate; Middle Aged; Time Factors; Transplantation, Homologous | 1985 |
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
Topics: Acyclovir; Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Etoposide; Female; Graft Survival; Graft vs Host Disease; Herpes Genitalis; HLA Antigens; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Nystatin; Prednisolone; Tissue Donors; Whole-Body Irradiation | 1985 |
Bone marrow transplantation for acute leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporins; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone | 1985 |
[Cyclosporin in allogeneic bone marrow transplantation].
Topics: Anemia, Aplastic; Bone Marrow; Bone Marrow Transplantation; Cyclosporins; Drug Therapy, Combination; Graft vs Host Disease; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Transplantation Immunology | 1985 |
Cyclosporin A pretreatment of both donor and recipient undergoing allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporins; Graft Survival; Graft vs Host Disease; Humans; Methotrexate | 1985 |
[Bone marrow transplantation in leukemia in remission or early relapse: preliminary data].
Topics: Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Catheterization; Child; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Specimen Handling | 1985 |
Present status of bone marrow transplantation in Japan.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporins; Graft vs Host Disease; Humans; Japan; Leukemia; Methotrexate; Transplantation, Autologous; Transplantation, Homologous; Transplantation, Isogeneic | 1985 |
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.
Topics: Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Gastrointestinal Diseases; Graft vs Host Disease; Graft vs Host Reaction; Histocompatibility Antigens; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Radiation Chimera; Skin Manifestations; Tissue Donors; Transplantation, Homologous | 1974 |
Rescue from canine graft-versus-host reaction by autologous or DL-A-compatible marrow.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Dogs; Female; Graft vs Host Disease; Graft vs Host Reaction; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Male; Methotrexate; Radiation Chimera; Time Factors; Transplantation, Autologous; Transplantation, Homologous | 1974 |
Bone-marrow transplantation in France, 1958-1973.
Topics: Animals; Antilymphocyte Serum; Blood Transfusion; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Drug Therapy, Combination; France; Friend murine leukemia virus; Graft vs Host Disease; Graft vs Host Reaction; Histocompatibility; Humans; Leukemia; Leukemia, Lymphoid; Methotrexate; Mice; Radiation Chimera; Radiation Injuries; Rats; Retroviridae; Transplantation Immunology; Transplantation, Heterologous; Transplantation, Homologous | 1974 |
Allogeneic marrow grafts in man using cyclophosphamide.
Topics: Amidines; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Cytomegalovirus; Graft vs Host Disease; Graft vs Host Reaction; Herpesviridae; Histocompatibility Testing; Humans; Immunologic Deficiency Syndromes; Injections, Spinal; Karyotyping; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocyte Culture Test, Mixed; Methotrexate; Phenyl Ethers; Pneumonia; Prednisone; Transplantation Immunology; Transplantation, Homologous | 1974 |
[The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice].
Topics: Age Factors; Aminopterin; Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Tolerance; Graft vs Host Disease; Immunosuppressive Agents; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Skin Transplantation; Thioguanine; Transplantation, Homologous | 1967 |
Marrow grafts between DL-A-matched canine littermates.
Topics: Animals; Blood Platelets; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Chromosomes; Cobalt Isotopes; Dogs; Graft vs Host Disease; Hematopoietic Stem Cells; Histocompatibility Antigens; Immunosuppression Therapy; Leukocyte Count; Leukocyte Transfusion; Leukocytes; Lymphocyte Culture Test, Mixed; Lymphocytes; Methotrexate; Radiation Effects; Thymidine; Time Factors; Transplantation Immunology; Transplantation, Homologous; Tritium | 1973 |
Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cobalt Isotopes; Dogs; Graft vs Host Disease; Graft vs Host Reaction; Histocompatibility; Histocompatibility Testing; Methotrexate; Radiation Effects; Time Factors; Transplantation, Homologous | 1970 |
Graft-versus-host reactions in bone marrow transplantation.
Topics: Adolescent; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Female; Graft vs Host Disease; Graft vs Host Reaction; Histocompatibility Testing; Humans; Infant; Male; Methotrexate; Transplantation Immunology; Transplantation, Homologous | 1971 |
Treatment of hyperacute graft-versus-host disease in mice with cytosine arabinoside.
Topics: Acute Disease; Animals; Antilymphocyte Serum; Cyclophosphamide; Cytarabine; Graft vs Host Disease; Graft vs Host Reaction; Lymphocyte Transfusion; Methods; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Procarbazine; Tissue Donors; Transplantation, Homologous | 1972 |
Antithymocyte serum and methotrexate for control of graft-versus-host disease in dogs.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Dogs; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Graft vs Host Disease; Hematopoietic Stem Cells; Immune Sera; Immunization, Passive; Immunosuppression Therapy; Methotrexate; Rabbits; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1973 |
Treatment of established graft-versus-host disease in dogs by antithymocyte serum or prednisone.
Topics: Animals; Antilymphocyte Serum; Blood Cell Count; Blood Platelets; Bone Marrow Cells; Bone Marrow Transplantation; Dogs; Graft Rejection; Graft vs Host Disease; Histocompatibility; Leukocyte Transfusion; Methotrexate; Prednisone; Rabbits; Radiation Chimera; Skin Transplantation; Thymus Gland; Transplantation, Homologous | 1973 |
Marrow transplantation in aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Transplantation; Child, Preschool; Cyclophosphamide; Female; Graft vs Host Disease; Hepatitis; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1974 |
Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
Topics: Acute Kidney Injury; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Female; Graft Rejection; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Pneumonia; Recurrence; Sepsis; T-Lymphocytes; Transplantation Immunology; Transplantation, Homologous | 1974 |
Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture.
Topics: Animals; Bone Marrow Transplantation; Culture Techniques; Dogs; Graft vs Host Disease; Histocompatibility; Immunosuppression Therapy; Leukocyte Count; Leukocytes; Methotrexate; Models, Biological; Serotyping; Transplantation, Homologous | 1971 |
The effect of cytotoxic drugs on graft-versus-host disease in mice.
Topics: Animals; Antibodies; Cyclophosphamide; Female; Graft vs Host Disease; Hydrocortisone; Immunoglobulins; Injections, Intraperitoneal; Mechlorethamine; Mercaptopurine; Methotrexate; Mice; Skin Transplantation; Time Factors; Transplantation Immunology; Transplantation, Homologous | 1971 |